Cancer treatment and survivorship statistics, 2012

Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CA: a cancer journal for clinicians Jg. 62; H. 4; S. 220 - 241
Hauptverfasser:	Siegel, Rebecca, DeSantis, Carol, Virgo, Katherine, Stein, Kevin, Mariotto, Angela, Smith, Tenbroeck, Cooper, Dexter, Gansler, Ted, Lerro, Catherine, Fedewa, Stacey, Lin, Chunchieh, Leach, Corinne, Cannady, Rachel Spillers, Cho, Hyunsoon, Scoppa, Steve, Hachey, Mark, Kirch, Rebecca, Jemal, Ahmedin, Ward, Elizabeth
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2012 Wiley Subscription Services, Inc
Schlagworte:	American Cancer Society Cancer Combined Modality Therapy Female Females Humans Incidence Male Neoplasms - epidemiology Neoplasms - therapy Oncology Prevalence Registries - statistics & numerical data SEER Program - statistics & numerical data Statistics Survival analysis Survival Rate - trends Survivor United States - epidemiology United States United States > US
ISSN:	0007-9235, 1542-4863, 1542-4863
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER‐Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. CA Cancer J Clin 2012. Published 2012 American Cancer Society.
AbstractList	Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. [PUBLICATION ABSTRACT] Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers.Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER‐Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. CA Cancer J Clin 2012. Published 2012 American Cancer Society. Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers.
Author	Fedewa, Stacey Jemal, Ahmedin Virgo, Katherine Hachey, Mark Stein, Kevin Siegel, Rebecca Leach, Corinne Cannady, Rachel Spillers Scoppa, Steve Kirch, Rebecca Gansler, Ted Smith, Tenbroeck Cooper, Dexter Lin, Chunchieh Ward, Elizabeth Mariotto, Angela DeSantis, Carol Cho, Hyunsoon Lerro, Catherine
Author_xml	– sequence: 1 givenname: Rebecca surname: Siegel fullname: Siegel, Rebecca email: rebecca.siegel@cancer.org – sequence: 2 givenname: Carol surname: DeSantis fullname: DeSantis, Carol – sequence: 3 givenname: Katherine surname: Virgo fullname: Virgo, Katherine – sequence: 4 givenname: Kevin surname: Stein fullname: Stein, Kevin – sequence: 5 givenname: Angela surname: Mariotto fullname: Mariotto, Angela – sequence: 6 givenname: Tenbroeck surname: Smith fullname: Smith, Tenbroeck – sequence: 7 givenname: Dexter surname: Cooper fullname: Cooper, Dexter – sequence: 8 givenname: Ted surname: Gansler fullname: Gansler, Ted – sequence: 9 givenname: Catherine surname: Lerro fullname: Lerro, Catherine – sequence: 10 givenname: Stacey surname: Fedewa fullname: Fedewa, Stacey – sequence: 11 givenname: Chunchieh surname: Lin fullname: Lin, Chunchieh – sequence: 12 givenname: Corinne surname: Leach fullname: Leach, Corinne – sequence: 13 givenname: Rachel Spillers surname: Cannady fullname: Cannady, Rachel Spillers – sequence: 14 givenname: Hyunsoon surname: Cho fullname: Cho, Hyunsoon – sequence: 15 givenname: Steve surname: Scoppa fullname: Scoppa, Steve – sequence: 16 givenname: Mark surname: Hachey fullname: Hachey, Mark – sequence: 17 givenname: Rebecca surname: Kirch fullname: Kirch, Rebecca – sequence: 18 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin – sequence: 19 givenname: Elizabeth surname: Ward fullname: Ward, Elizabeth
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/22700443$$D View this record in MEDLINE/PubMed
BookMark	eNp90E1LwzAYB_AgE_eiFz-AFLyI2Jm3JstxFN9g4EXPJU1TzGjTmaSTfXvbdXoY4ik88Ps_5PlPwcg2VgNwieCcEIzvlZRqjhGi4gRMUEJxTBeMjMAEQshjgUkyBlPv17CfOT8DY4w5hJSSCcCptEq7KDgtQ61tiKQtIt-6rdk2zn-YTeSDDMYHo_xdhCHC5-C0lJXXF4d3Bt4fH97S53j1-vSSLlexookQ8UJqKpmmMBeC85InQmKOmNJUa1kUlCZMMFUyrEjenUFYsuhmiRApBFU5JDNwM-zduOaz1T5ktfFKV5W0uml9hiCmlDNGUEevj-i6aZ3tfrdXCe0P79TVQbV5rYts40wt3S77aaMDtwNQrvHe6fKXIJj1VWd91dm-6g7DI6xM31Rjg5Om-juChsiXqfTun-VZulymQ-Ybe62M6g
CODEN	CAMCAM
CitedBy_id	crossref_primary_10_1007_s12350_018_01584_w crossref_primary_10_3892_mco_2015_610 crossref_primary_10_1200_JCO_2012_46_5765 crossref_primary_10_1155_2020_4894625 crossref_primary_10_1016_j_canlet_2012_10_008 crossref_primary_10_1016_j_jneb_2012_10_009 crossref_primary_10_17656_jsmc_10377 crossref_primary_10_1002_cam4_428 crossref_primary_10_1016_j_jval_2016_02_010 crossref_primary_10_2147_CMAR_S299089 crossref_primary_10_1371_journal_pone_0120232 crossref_primary_10_4155_tde_15_93 crossref_primary_10_3389_fphar_2021_636213 crossref_primary_10_1016_j_jconrel_2013_12_012 crossref_primary_10_1371_journal_pone_0110412 crossref_primary_10_1136_bmjopen_2013_002869 crossref_primary_10_1007_s11596_018_1946_6 crossref_primary_10_1186_s12967_014_0215_0 crossref_primary_10_1186_1472_6882_14_299 crossref_primary_10_3892_mmr_2016_5869 crossref_primary_10_3810_pgm_2012_09_2596 crossref_primary_10_1371_journal_pone_0154009 crossref_primary_10_1007_s00520_014_2551_2 crossref_primary_10_1016_j_jconrel_2013_12_027 crossref_primary_10_1007_s11764_015_0513_4 crossref_primary_10_1002_pros_24885 crossref_primary_10_1186_s12935_015_0250_9 crossref_primary_10_1080_10428194_2016_1219904 crossref_primary_10_1093_annonc_mdu012 crossref_primary_10_1309_AJCPI5YHG0OGFAHM crossref_primary_10_3892_ol_2015_3856 crossref_primary_10_1038_nrgastro_2014_46 crossref_primary_10_1007_s40257_016_0186_4 crossref_primary_10_1002_pros_22698 crossref_primary_10_3390_ijms21249396 crossref_primary_10_1136_bmjopen_2017_016913 crossref_primary_10_1016_j_jnutbio_2015_06_004 crossref_primary_10_1007_s00261_018_1848_x crossref_primary_10_1002_qua_27106 crossref_primary_10_1016_j_ejca_2017_07_052 crossref_primary_10_3390_genes9090439 crossref_primary_10_1007_s11894_013_0355_z crossref_primary_10_1134_S1062359024701334 crossref_primary_10_1016_j_ypmed_2014_12_019 crossref_primary_10_1002_2211_5463_12623 crossref_primary_10_1002_jcb_24896 crossref_primary_10_1021_acs_analchem_5c01597 crossref_primary_10_1002_cncr_32583 crossref_primary_10_3233_CBM_160240 crossref_primary_10_1111_scs_12797 crossref_primary_10_1631_jzus_B1500258 crossref_primary_10_3892_ol_2016_5425 crossref_primary_10_1186_s12885_021_08989_w crossref_primary_10_1016_j_biopha_2015_04_016 crossref_primary_10_1007_s10549_015_3363_x crossref_primary_10_1007_s00403_017_1784_6 crossref_primary_10_1158_1940_6207_CAPR_13_0050 crossref_primary_10_1002_jhet_2768 crossref_primary_10_1016_j_fct_2017_07_005 crossref_primary_10_1177_1535370216669611 crossref_primary_10_1016_j_mpmed_2019_04_001 crossref_primary_10_1007_s00520_014_2279_z crossref_primary_10_1016_j_ijcard_2021_02_025 crossref_primary_10_4155_fmc_12_210 crossref_primary_10_3389_fcimb_2021_586392 crossref_primary_10_1093_jrr_rrw075 crossref_primary_10_30621_jbachs_1040841 crossref_primary_10_1007_s40261_023_01329_9 crossref_primary_10_1080_17425255_2017_1351547 crossref_primary_10_1097_DAD_0b013e3182964e02 crossref_primary_10_1371_journal_pone_0131305 crossref_primary_10_1097_MD_0000000000001955 crossref_primary_10_1007_s13187_018_1374_0 crossref_primary_10_1158_1541_7786_MCR_16_0346 crossref_primary_10_1200_JCO_2012_45_3753 crossref_primary_10_1016_j_juro_2012_10_030 crossref_primary_10_1371_journal_pone_0121535 crossref_primary_10_1186_1741_7015_12_55 crossref_primary_10_1007_s00216_014_7865_x crossref_primary_10_2217_imt_14_92 crossref_primary_10_3390_cells8070713 crossref_primary_10_1016_j_oraloncology_2014_03_007 crossref_primary_10_1186_s13012_015_0254_9 crossref_primary_10_1093_jnci_djt450 crossref_primary_10_3390_cancers6010396 crossref_primary_10_4137_CMRH_S10415 crossref_primary_10_1155_2019_7138754 crossref_primary_10_1007_s00280_015_2841_5 crossref_primary_10_1158_1078_0432_CCR_14_3173 crossref_primary_10_3109_10428194_2014_901513 crossref_primary_10_1142_S0192415X1550072X crossref_primary_10_1016_j_prp_2024_155386 crossref_primary_10_1053_j_ro_2013_03_005 crossref_primary_10_1007_s00520_019_04899_7 crossref_primary_10_1016_j_ijbiomac_2018_07_188 crossref_primary_10_1080_07391102_2020_1800512 crossref_primary_10_1002_cncr_34329 crossref_primary_10_3322_caac_21349 crossref_primary_10_3322_caac_21341 crossref_primary_10_4103_1673_5374_135315 crossref_primary_10_3389_fbioe_2024_1424553 crossref_primary_10_1016_j_ejmech_2016_02_031 crossref_primary_10_1371_journal_pone_0106322 crossref_primary_10_1097_CEJ_0000000000000251 crossref_primary_10_1080_17425247_2018_1547280 crossref_primary_10_1186_s12885_019_6495_2 crossref_primary_10_1007_s00345_018_2174_1 crossref_primary_10_1038_srep12493 crossref_primary_10_1007_s11884_019_00544_5 crossref_primary_10_1519_JPT_0000000000000047 crossref_primary_10_2174_1570180815666180801115526 crossref_primary_10_1177_1756287215576626 crossref_primary_10_1007_s13277_012_0567_0 crossref_primary_10_3892_mmr_2014_2742 crossref_primary_10_3233_CBM_201740 crossref_primary_10_1111_1759_7714_12286 crossref_primary_10_1016_j_canlet_2013_09_001 crossref_primary_10_1016_j_bios_2019_111868 crossref_primary_10_1021_acsbiomaterials_8b00904 crossref_primary_10_1016_j_clbc_2013_10_013 crossref_primary_10_3945_ajcn_116_150565 crossref_primary_10_1007_s00520_016_3163_9 crossref_primary_10_1200_JCO_2014_59_8391 crossref_primary_10_1371_journal_pone_0089350 crossref_primary_10_1016_j_aca_2016_07_040 crossref_primary_10_1161_JAHA_113_000432 crossref_primary_10_3892_ijo_2013_2136 crossref_primary_10_3390_s23198017 crossref_primary_10_1016_j_cca_2017_02_005 crossref_primary_10_1016_j_ppedcard_2014_09_008 crossref_primary_10_1053_j_seminoncol_2013_09_004 crossref_primary_10_1016_j_clcc_2014_06_001 crossref_primary_10_1002_cam4_5553 crossref_primary_10_1111_jgs_12269 crossref_primary_10_1186_1471_2407_14_227 crossref_primary_10_1038_oncsis_2015_7 crossref_primary_10_1007_s12032_014_0868_9 crossref_primary_10_1371_journal_pone_0118332 crossref_primary_10_1080_17446651_2016_1216101 crossref_primary_10_1016_j_clcc_2015_05_009 crossref_primary_10_2217_bmm_2020_0141 crossref_primary_10_1007_s00404_014_3264_y crossref_primary_10_1089_jpm_2015_0032 crossref_primary_10_1080_09603123_2022_2133095 crossref_primary_10_1016_j_clml_2021_08_002 crossref_primary_10_1016_j_pharmthera_2013_06_005 crossref_primary_10_1158_0008_5472_CAN_13_1531 crossref_primary_10_1186_s12885_025_14031_0 crossref_primary_10_1186_s12885_018_4020_7 crossref_primary_10_1002_cncr_28922 crossref_primary_10_1007_s00277_014_2048_6 crossref_primary_10_1016_j_urolonc_2020_06_005 crossref_primary_10_3389_fgene_2020_00352 crossref_primary_10_3892_mmr_2015_3455 crossref_primary_10_1016_j_jep_2017_07_023 crossref_primary_10_1007_s00520_016_3141_2 crossref_primary_10_1016_j_lungcan_2015_01_027 crossref_primary_10_1016_j_phrs_2013_11_002 crossref_primary_10_1111_jep_12529 crossref_primary_10_1002_cncr_28518 crossref_primary_10_1186_s12889_016_3592_x crossref_primary_10_1002_pros_23101 crossref_primary_10_1089_gtmb_2017_0113 crossref_primary_10_1002_pros_24898 crossref_primary_10_1371_journal_pone_0054269 crossref_primary_10_3390_ijerph110605567 crossref_primary_10_3390_ijms18040743 crossref_primary_10_3390_molecules28165990 crossref_primary_10_1093_annonc_mds289 crossref_primary_10_1093_annonc_mdt136 crossref_primary_10_1097_MCG_0000000000000662 crossref_primary_10_1074_jbc_M116_727727 crossref_primary_10_1007_s10147_023_02441_8 crossref_primary_10_1016_j_urology_2015_01_022 crossref_primary_10_1155_2018_6483626 crossref_primary_10_1016_j_homp_2013_06_001 crossref_primary_10_1177_1534735415572886 crossref_primary_10_2196_cancer_4389 crossref_primary_10_1007_s00216_020_02903_2 crossref_primary_10_2147_CMAR_S279427 crossref_primary_10_2478_raon_2013_0053 crossref_primary_10_7759_cureus_59461 crossref_primary_10_1002_cbic_201402237 crossref_primary_10_1158_2326_6066_CIR_18_0179 crossref_primary_10_1177_11795549241288197 crossref_primary_10_14694_EdBook_AM_2014_34_91 crossref_primary_10_5306_wjco_v5_i2_177 crossref_primary_10_1007_s12032_012_0337_2 crossref_primary_10_1158_1078_0432_CCR_14_0516 crossref_primary_10_3322_caac_21754 crossref_primary_10_3748_wjg_v20_i37_13246 crossref_primary_10_1016_j_jdermsci_2014_02_007 crossref_primary_10_1186_s12876_024_03286_9 crossref_primary_10_1016_j_amepre_2013_11_016 crossref_primary_10_1016_j_prp_2018_12_032 crossref_primary_10_1007_s12325_018_0701_5 crossref_primary_10_3389_fonc_2023_1129989 crossref_primary_10_1177_000313481708300631 crossref_primary_10_1007_s12011_015_0323_6 crossref_primary_10_17795_ijcp_3919 crossref_primary_10_1002_cncr_29811 crossref_primary_10_1016_j_jchromb_2019_121734 crossref_primary_10_1111_jsm_12077 crossref_primary_10_3892_ol_2018_8141 crossref_primary_10_1111_jsm_12078 crossref_primary_10_1016_j_canlet_2013_09_012 crossref_primary_10_1186_s12889_024_20000_2 crossref_primary_10_1007_s00216_014_7967_5 crossref_primary_10_3389_fonc_2014_00299 crossref_primary_10_1007_s11912_017_0601_x crossref_primary_10_1051_bioconf_202411102020 crossref_primary_10_1007_s11912_017_0623_4 crossref_primary_10_1172_JCI66776 crossref_primary_10_1051_bioconf_202411102017 crossref_primary_10_1016_j_eururo_2014_09_028 crossref_primary_10_1007_s12032_014_0088_3 crossref_primary_10_1051_bioconf_202411102018 crossref_primary_10_1007_s10735_016_9674_3 crossref_primary_10_1111_obr_12534 crossref_primary_10_1038_mt_2014_174 crossref_primary_10_1016_j_biopha_2019_109614 crossref_primary_10_1007_s10549_014_2994_7 crossref_primary_10_2217_fon_15_194 crossref_primary_10_3390_cancers14030683 crossref_primary_10_1111_ajco_13937 crossref_primary_10_1007_s11936_018_0645_8 crossref_primary_10_3390_ijms16010307 crossref_primary_10_1007_s13187_018_1338_4 crossref_primary_10_1590_0037_8682_0022_2013 crossref_primary_10_1007_s11605_018_3666_4 crossref_primary_10_1093_carcin_bgt316 crossref_primary_10_1097_00001416_201400001_00010 crossref_primary_10_3389_fmed_2022_845905 crossref_primary_10_1136_bjsports_2012_091732 crossref_primary_10_1007_s13277_015_4341_y crossref_primary_10_2196_resprot_2440 crossref_primary_10_1002_cncr_28416 crossref_primary_10_1016_j_ejmech_2024_116497 crossref_primary_10_1016_j_radonc_2014_08_013 crossref_primary_10_1016_j_jclinane_2013_10_004 crossref_primary_10_1002_adma_201503869 crossref_primary_10_1080_17437199_2019_1618725 crossref_primary_10_1007_s11033_020_06075_1 crossref_primary_10_1186_s13000_022_01230_7 crossref_primary_10_1111_jsm_12555 crossref_primary_10_1016_j_bbi_2013_01_003 crossref_primary_10_5812_ijcm_8173 crossref_primary_10_1080_08870446_2018_1456659 crossref_primary_10_3892_ol_2013_1635 crossref_primary_10_1016_j_saa_2021_120458 crossref_primary_10_1002_cncr_28884 crossref_primary_10_1016_j_urolonc_2013_08_003 crossref_primary_10_1038_srep40585 crossref_primary_10_1016_j_urolonc_2014_03_005 crossref_primary_10_1111_ecc_13193 crossref_primary_10_3389_fcvm_2021_634291 crossref_primary_10_1016_j_ctrv_2023_102605 crossref_primary_10_1155_2018_5690258 crossref_primary_10_4161_onci_25595 crossref_primary_10_14694_EdBook_AM_2014_34_e57 crossref_primary_10_1016_j_jbo_2023_100485 crossref_primary_10_2174_0109298673348662241210111400 crossref_primary_10_3892_ijo_2017_4047 crossref_primary_10_1016_j_jep_2015_02_015 crossref_primary_10_1002_mc_22204 crossref_primary_10_1136_jclinpath_2013_201626 crossref_primary_10_3390_jpm12071154 crossref_primary_10_1039_C9SC02651G crossref_primary_10_2217_nnm_15_61 crossref_primary_10_1111_pcmr_12352 crossref_primary_10_1016_j_juro_2014_02_003 crossref_primary_10_1158_0008_5472_CAN_16_0587 crossref_primary_10_1007_s11886_017_0873_7 crossref_primary_10_3748_wjg_v20_i30_10425 crossref_primary_10_1093_ehjcr_ytz048 crossref_primary_10_1186_s12885_018_4607_z crossref_primary_10_1007_s00345_013_1045_z crossref_primary_10_3748_wjg_v25_i17_2099 crossref_primary_10_1002_ehf2_12005 crossref_primary_10_1016_j_ijgo_2015_06_042 crossref_primary_10_1016_j_canlet_2016_07_028 crossref_primary_10_1007_s10549_014_2928_4 crossref_primary_10_1002_chem_201502809 crossref_primary_10_3389_fonc_2020_588557 crossref_primary_10_3892_mco_2014_334 crossref_primary_10_1158_1078_0432_CCR_15_2042 crossref_primary_10_1080_09168451_2017_1387048 crossref_primary_10_1016_j_scr_2017_06_006 crossref_primary_10_1097_MD_0000000000001055 crossref_primary_10_1016_j_humpath_2013_06_011 crossref_primary_10_1111_cbdd_13013 crossref_primary_10_1002_jcb_30326 crossref_primary_10_1016_j_mednuc_2012_11_004 crossref_primary_10_7314_APJCP_2014_15_19_8469 crossref_primary_10_5966_sctm_2014_0119 crossref_primary_10_1016_j_suronc_2018_03_001 crossref_primary_10_3103_S0095452723040047 crossref_primary_10_3390_jcdd10060232 crossref_primary_10_3109_07357907_2014_958497 crossref_primary_10_1016_j_eururo_2014_10_033 crossref_primary_10_14694_EdBook_AM_2015_35_e583 crossref_primary_10_1007_s11936_017_0535_5 crossref_primary_10_1002_cncr_28447 crossref_primary_10_1111_joim_12097 crossref_primary_10_1155_2013_460546 crossref_primary_10_1155_2014_478126 crossref_primary_10_1517_13543784_2013_787409 crossref_primary_10_1136_gutjnl_2017_314711 crossref_primary_10_1002_ptr_5327 crossref_primary_10_1038_bjc_2017_88 crossref_primary_10_1016_j_biomaterials_2019_119265 crossref_primary_10_1042_BSR20203496 crossref_primary_10_1016_j_ijrobp_2013_11_004 crossref_primary_10_1186_s12885_018_4477_4 crossref_primary_10_1016_j_jgg_2013_02_001 crossref_primary_10_1111_bjh_14292 crossref_primary_10_1111_tbj_12302 crossref_primary_10_1016_j_ijrobp_2014_05_021 crossref_primary_10_1002_jcb_24946 crossref_primary_10_1016_j_bbrc_2013_05_123 crossref_primary_10_1016_j_jsbmb_2013_12_010 crossref_primary_10_1177_0003702816681009 crossref_primary_10_1016_j_molonc_2014_05_003 crossref_primary_10_1080_07347332_2014_897782 crossref_primary_10_1038_tpj_2013_8 crossref_primary_10_1186_gm393 crossref_primary_10_1002_cncr_28028 crossref_primary_10_1007_s00432_014_1874_1 crossref_primary_10_3389_fbioe_2022_866970 crossref_primary_10_1007_s13277_015_3882_4 crossref_primary_10_1016_j_mgene_2019_100621 crossref_primary_10_1097_01_NPR_0000429893_95631_63 crossref_primary_10_1016_j_clgc_2015_07_006 crossref_primary_10_1016_j_retram_2018_03_005 crossref_primary_10_1007_s10637_020_00919_0 crossref_primary_10_1590_S0102_86502016001300008 crossref_primary_10_3892_or_2013_2852 crossref_primary_10_1007_s11764_012_0259_1 crossref_primary_10_1148_radiol_2018171504 crossref_primary_10_1371_journal_pone_0126875 crossref_primary_10_1891_1541_6577_27_4_257 crossref_primary_10_3390_ijerph19052524 crossref_primary_10_1097_CCO_0000000000000033 crossref_primary_10_1111_cbdd_13848 crossref_primary_10_3390_cancers12051348 crossref_primary_10_1177_2381468319855386 crossref_primary_10_1016_j_biopha_2016_10_025 crossref_primary_10_3390_ijms140918973 crossref_primary_10_1136_bmjopen_2022_068997 crossref_primary_10_3390_biomedicines11071798 crossref_primary_10_3892_or_2015_4266 crossref_primary_10_1371_journal_pone_0052984 crossref_primary_10_1051_bmdcn_2017070423 crossref_primary_10_1088_0031_9155_60_17_6923 crossref_primary_10_1007_s00520_019_05164_7 crossref_primary_10_1111_cbdd_12528 crossref_primary_10_5604_01_3001_0015_5540 crossref_primary_10_1016_j_gene_2017_01_023 crossref_primary_10_3390_molecules26030550 crossref_primary_10_3892_ol_2016_4591 crossref_primary_10_5301_jbm_5000085 crossref_primary_10_3892_ol_2016_5025 crossref_primary_10_7759_cureus_10210 crossref_primary_10_1016_j_hfc_2016_12_012 crossref_primary_10_2106_JBJS_19_00419 crossref_primary_10_1002_cncr_28076 crossref_primary_10_1007_s10147_020_01856_x crossref_primary_10_1089_ars_2016_6641 crossref_primary_10_3389_fonc_2017_00083 crossref_primary_10_1007_s00432_015_2016_0 crossref_primary_10_1007_s00066_018_1318_y crossref_primary_10_1016_j_biopha_2016_12_097 crossref_primary_10_1080_0284186X_2020_1828620 crossref_primary_10_2217_bmt_14_41 crossref_primary_10_4103_1742_6413_149845 crossref_primary_10_1007_s00109_017_1558_9 crossref_primary_10_1097_MD_0000000000022806 crossref_primary_10_3390_pharmaceutics15041148 crossref_primary_10_1016_S1470_2045_14_70012_9 crossref_primary_10_1109_TBME_2013_2267452 crossref_primary_10_1017_S0959259814000069 crossref_primary_10_3892_or_2016_4825 crossref_primary_10_1002_ncp_11039 crossref_primary_10_1155_2017_6950579 crossref_primary_10_1007_s10620_018_5424_6 crossref_primary_10_1186_1471_2407_14_191 crossref_primary_10_1016_j_mric_2013_07_006 crossref_primary_10_1002_pmic_201500489 crossref_primary_10_1097_JWH_0000000000000020 crossref_primary_10_1007_s13187_021_02037_8 crossref_primary_10_1002_cnr2_1172 crossref_primary_10_1186_s12872_020_01497_y crossref_primary_10_1089_thy_2017_0199 crossref_primary_10_1002_jso_26102 crossref_primary_10_1186_1479_5876_12_36 crossref_primary_10_5306_wjco_v5_i4_693 crossref_primary_10_1038_s41419_020_02915_x crossref_primary_10_1093_ajcp_aqw068 crossref_primary_10_1667_RR14315_1 crossref_primary_10_1186_s13046_017_0594_1 crossref_primary_10_1080_01969722_2022_2157608 crossref_primary_10_1155_2019_8409406 crossref_primary_10_1007_s00520_017_3994_z crossref_primary_10_1186_s13063_021_05948_5 crossref_primary_10_1016_j_jpeds_2017_12_049 crossref_primary_10_1097_MPA_0000000000000095 crossref_primary_10_1186_s12935_017_0478_7 crossref_primary_10_1186_s12865_016_0167_7 crossref_primary_10_1586_14737140_2015_1052412 crossref_primary_10_3892_ol_2013_1275 crossref_primary_10_1111_crj_12637 crossref_primary_10_3390_diagnostics12071685 crossref_primary_10_5812_ijcm_11743 crossref_primary_10_1038_srep04480 crossref_primary_10_1016_j_molonc_2013_10_003 crossref_primary_10_1159_000364857 crossref_primary_10_1016_j_biopha_2018_08_140 crossref_primary_10_1038_srep03151 crossref_primary_10_1159_000456534 crossref_primary_10_1093_eurheartj_ehw211 crossref_primary_10_1158_1078_0432_CCR_21_0360 crossref_primary_10_1016_j_cancergen_2017_07_005 crossref_primary_10_1039_D4NR01740D crossref_primary_10_2147_CMAR_S339988 crossref_primary_10_1093_eurheartj_ehu025 crossref_primary_10_1016_j_bbrc_2013_01_089 crossref_primary_10_1080_17415993_2023_2255711 crossref_primary_10_1016_j_ygyno_2014_03_015 crossref_primary_10_1186_s12955_017_0673_1 crossref_primary_10_14694_EdBook_AM_2014_34_e423 crossref_primary_10_1002_ijc_28788 crossref_primary_10_1111_sms_12193 crossref_primary_10_1158_1078_0432_CCR_16_0471 crossref_primary_10_3892_ol_2015_3702 crossref_primary_10_1097_MOP_0000000000000675 crossref_primary_10_1007_s00432_023_05390_x crossref_primary_10_1002_cncr_32489 crossref_primary_10_1007_s13187_019_01588_1 crossref_primary_10_1016_j_ccm_2013_04_005 crossref_primary_10_1096_fj_201800222RRR crossref_primary_10_1371_journal_pone_0249632 crossref_primary_10_1038_s41598_020_62369_1 crossref_primary_10_1007_s10620_013_2690_1 crossref_primary_10_3389_fonc_2020_00628 crossref_primary_10_1586_14737159_2014_943665 crossref_primary_10_3892_ol_2015_3730 crossref_primary_10_1186_s12881_018_0529_5 crossref_primary_10_2217_bmm_13_115 crossref_primary_10_2147_IJN_S281029 crossref_primary_10_1155_2014_591867 crossref_primary_10_1002_pon_3988 crossref_primary_10_1016_j_ejmech_2021_113725 crossref_primary_10_1016_j_jjcc_2023_07_002 crossref_primary_10_1016_j_semcancer_2014_04_005 crossref_primary_10_1016_j_bcp_2013_11_008 crossref_primary_10_1016_j_tjog_2013_02_002 crossref_primary_10_1245_s10434_018_6365_1 crossref_primary_10_1093_annonc_mdt037 crossref_primary_10_1016_j_wds_2025_100215 crossref_primary_10_1093_icvts_ivv062 crossref_primary_10_3892_ol_2017_6231 crossref_primary_10_1002_pon_3509 crossref_primary_10_1016_j_engappai_2024_109926 crossref_primary_10_1007_s00520_014_2596_2 crossref_primary_10_1186_s12943_022_01495_y crossref_primary_10_1007_s11764_013_0269_7 crossref_primary_10_1186_1471_230X_13_101 crossref_primary_10_1309_AJCPNOC55IOLXFUD crossref_primary_10_1016_j_pepo_2017_03_004 crossref_primary_10_3748_wjg_v20_i38_13820 crossref_primary_10_1016_j_ctrv_2018_07_003 crossref_primary_10_1016_j_ejim_2013_12_003 crossref_primary_10_3390_genes14051002 crossref_primary_10_1038_ncomms14797 crossref_primary_10_1007_s11033_013_2850_6 crossref_primary_10_1080_14656566_2016_1176148 crossref_primary_10_1245_s10434_023_14806_4 crossref_primary_10_1093_jncics_pkaa017 crossref_primary_10_1097_RLI_0b013e3182982cc1 crossref_primary_10_1517_17460441_2013_768983 crossref_primary_10_1007_s13277_015_3371_9 crossref_primary_10_1002_jhet_3720 crossref_primary_10_1371_journal_pone_0133852 crossref_primary_10_3389_fphys_2022_857538 crossref_primary_10_1016_j_intimp_2015_04_011 crossref_primary_10_1097_PPO_0000000000000139 crossref_primary_10_1089_jir_2018_0024 crossref_primary_10_1159_000441226 crossref_primary_10_1016_j_inoche_2023_110982 crossref_primary_10_1007_s13277_013_1527_z crossref_primary_10_1016_j_eururo_2013_03_041 crossref_primary_10_1038_bjc_2017_198 crossref_primary_10_1089_thy_2016_0387 crossref_primary_10_3892_mmr_2013_1272 crossref_primary_10_1177_1043659614561678 crossref_primary_10_1007_s10620_014_3516_5 crossref_primary_10_1517_14712598_2015_1050375 crossref_primary_10_1111_jgs_13680 crossref_primary_10_1016_j_jpba_2019_113055 crossref_primary_10_1186_s12885_015_1284_z crossref_primary_10_1002_cam4_5477 crossref_primary_10_3892_ol_2017_6259 crossref_primary_10_1016_j_biopha_2018_12_150 crossref_primary_10_1016_j_canlet_2016_03_033 crossref_primary_10_1186_s13256_018_1606_2 crossref_primary_10_1200_JCO_2012_45_3886 crossref_primary_10_1038_s41598_023_51028_w crossref_primary_10_1074_jbc_M114_559047 crossref_primary_10_1016_j_ucl_2018_03_011 crossref_primary_10_1002_pon_3957 crossref_primary_10_3109_14756366_2014_948435 crossref_primary_10_1016_j_bioorg_2016_10_001 crossref_primary_10_1186_s12885_020_06855_9 crossref_primary_10_18632_oncotarget_15578 crossref_primary_10_1007_s11764_013_0323_5 crossref_primary_10_1002_cncr_31174 crossref_primary_10_1038_s41598_017_08436_6 crossref_primary_10_1016_j_tjog_2012_09_003 crossref_primary_10_3892_mmr_2016_4820 crossref_primary_10_1016_j_rmr_2014_07_016 crossref_primary_10_1155_2018_1495768 crossref_primary_10_1155_2014_708383 crossref_primary_10_1177_0300060517750298 crossref_primary_10_1016_j_apmr_2016_12_023 crossref_primary_10_1111_cas_12580 crossref_primary_10_1186_s12957_015_0588_4 crossref_primary_10_3390_ijms25053066 crossref_primary_10_1007_s10585_015_9759_5 crossref_primary_10_1093_jnci_djv371 crossref_primary_10_2174_0929867329666220820125638 crossref_primary_10_1093_jnci_dju044 crossref_primary_10_1038_aps_2014_18 crossref_primary_10_1080_10810730_2015_1018576 crossref_primary_10_1007_s12574_017_0344_6 crossref_primary_10_1073_pnas_2017148118 crossref_primary_10_1200_JCO_2013_50_3409 crossref_primary_10_1186_s13046_020_01642_7 crossref_primary_10_1021_mp500747w crossref_primary_10_1016_j_juro_2014_01_087 crossref_primary_10_1093_jnci_dju057 crossref_primary_10_1186_s12943_015_0367_4 crossref_primary_10_1016_j_canlet_2018_08_019 crossref_primary_10_1093_jnci_djv382 crossref_primary_10_1016_j_gtc_2012_11_007 crossref_primary_10_1007_s11764_016_0537_4 crossref_primary_10_1007_s00432_015_2040_0 crossref_primary_10_3103_S0095452723020044 crossref_primary_10_1002_cam4_968 crossref_primary_10_3390_life12081275 crossref_primary_10_1097_MD_0000000000034378 crossref_primary_10_1200_JCO_2017_72_4203 crossref_primary_10_1186_s40360_017_0181_2 crossref_primary_10_1093_abbs_gmv039 crossref_primary_10_1177_1043659614524254 crossref_primary_10_1016_j_amjoto_2014_10_008 crossref_primary_10_1007_s12682_014_0182_5 crossref_primary_10_1158_0008_5472_CAN_15_1423 crossref_primary_10_1038_s41598_020_77734_3 crossref_primary_10_4103_0366_6999_244101 crossref_primary_10_1016_j_jconrel_2015_11_016 crossref_primary_10_1007_s11010_016_2883_y crossref_primary_10_1200_JCO_2014_58_7543 crossref_primary_10_1038_cddis_2015_195 crossref_primary_10_1016_j_oooo_2014_03_019 crossref_primary_10_3390_ijms131013240 crossref_primary_10_1371_journal_pone_0070604 crossref_primary_10_1016_j_soncn_2014_05_005 crossref_primary_10_3892_mmr_2015_3334 crossref_primary_10_4137_CMO_S10269 crossref_primary_10_1007_s11764_014_0366_2 crossref_primary_10_1007_s00384_014_2065_x crossref_primary_10_1371_journal_pone_0159179 crossref_primary_10_1016_j_rcl_2014_07_014 crossref_primary_10_1186_s12986_017_0180_8 crossref_primary_10_1007_s13187_019_01673_5 crossref_primary_10_5472_marumj_1089686 crossref_primary_10_3390_ijms14024163 crossref_primary_10_1002_cam4_900 crossref_primary_10_1111_apm_13041 crossref_primary_10_1007_s10549_013_2630_y crossref_primary_10_1093_carcin_bgu192 crossref_primary_10_3892_or_2013_2473 crossref_primary_10_18087_cardio_2514 crossref_primary_10_1016_j_lungcan_2018_06_007 crossref_primary_10_1080_10717544_2021_1931559 crossref_primary_10_1093_annonc_mdt030 crossref_primary_10_1007_s00259_015_3134_2 crossref_primary_10_1111_1759_7714_12384 crossref_primary_10_1007_s10904_022_02259_3 crossref_primary_10_1016_j_soc_2012_12_003 crossref_primary_10_1016_j_ygyno_2013_08_027 crossref_primary_10_1007_s10637_014_0115_4 crossref_primary_10_1161_CIRCULATIONAHA_121_055920 crossref_primary_10_1200_JCO_2013_53_5948 crossref_primary_10_1111_jfbc_14302 crossref_primary_10_1021_jacs_3c09444 crossref_primary_10_4161_21624011_2014_954929 crossref_primary_10_3390_jcdd9030066 crossref_primary_10_1155_2016_2832980 crossref_primary_10_1556_OH_2013_29629 crossref_primary_10_1016_j_radonc_2017_08_020 crossref_primary_10_2147_DDDT_S306684 crossref_primary_10_1186_s12971_014_0025_4 crossref_primary_10_1016_j_canlet_2014_02_026 crossref_primary_10_1038_leu_2014_81 crossref_primary_10_1177_0260106015594098 crossref_primary_10_4103_IJPC_IJPC_1_19 crossref_primary_10_1002_clc_23097 crossref_primary_10_1186_s12885_016_2466_z crossref_primary_10_2217_fon_2016_0373 crossref_primary_10_1007_s00345_017_2072_y crossref_primary_10_1007_s00280_019_03885_4 crossref_primary_10_1371_journal_pone_0124094 crossref_primary_10_4155_fmc_2020_0110 crossref_primary_10_1007_s00726_018_2581_z crossref_primary_10_15252_emmm_201404874 crossref_primary_10_1016_j_soc_2017_11_007 crossref_primary_10_1186_s12967_015_0613_y crossref_primary_10_1177_1533033820980074 crossref_primary_10_3109_0284186X_2014_887224 crossref_primary_10_1053_j_seminoncol_2013_01_001 crossref_primary_10_2217_fon_2016_0383 crossref_primary_10_1007_s10120_013_0297_z crossref_primary_10_1016_j_bbrc_2016_01_094 crossref_primary_10_3390_ph15050504 crossref_primary_10_1155_2022_4033373 crossref_primary_10_2147_CLEP_S399488 crossref_primary_10_14694_EdBook_AM_2013_33_e50 crossref_primary_10_1007_s00520_013_1962_9 crossref_primary_10_1016_j_canep_2017_10_012 crossref_primary_10_3109_10428194_2014_903589 crossref_primary_10_1016_j_urology_2015_01_051 crossref_primary_10_1080_21655979_2021_1956402 crossref_primary_10_1517_14712598_2014_890182 crossref_primary_10_1007_s00595_024_02913_y crossref_primary_10_1007_s00330_019_06063_5 crossref_primary_10_1007_s11764_015_0454_y crossref_primary_10_3892_etm_2014_1913 crossref_primary_10_3748_wjg_v22_i2_790 crossref_primary_10_1016_j_cancergen_2016_10_006 crossref_primary_10_1038_srep05410 crossref_primary_10_1007_s00223_014_9839_6 crossref_primary_10_3390_toxins8070206 crossref_primary_10_1007_s11764_020_00976_7 crossref_primary_10_3389_fonc_2021_655856 crossref_primary_10_1038_s41598_018_19949_z crossref_primary_10_12954_PI_13020 crossref_primary_10_1038_cgt_2013_16 crossref_primary_10_3892_mmr_2014_2688 crossref_primary_10_1016_j_ejso_2018_05_010 crossref_primary_10_1016_j_hfc_2019_06_010 crossref_primary_10_1016_j_oraloncology_2016_12_028 crossref_primary_10_3928_01484834_20130529_01 crossref_primary_10_1016_j_beha_2013_09_001 crossref_primary_10_1186_s12935_017_0394_x crossref_primary_10_1186_1471_2407_14_974 crossref_primary_10_1002_pmic_201200319 crossref_primary_10_1002_jso_23569 crossref_primary_10_1097_JOM_0000000000000621 crossref_primary_10_1158_0008_5472_CAN_14_3485 crossref_primary_10_1097_MOU_0b013e32835f4b6b crossref_primary_10_1007_s00018_015_1930_2 crossref_primary_10_1016_j_canlet_2013_01_010 crossref_primary_10_1002_anie_202218613 crossref_primary_10_1093_ejcts_ezab294 crossref_primary_10_1007_s00268_014_2804_8 crossref_primary_10_1177_0961203317713146 crossref_primary_10_1007_s13187_013_0469_x crossref_primary_10_1177_2167702613496243 crossref_primary_10_3390_children9091287 crossref_primary_10_3390_ijms19103014 crossref_primary_10_1016_j_bbrc_2014_06_134 crossref_primary_10_31083_j_fbl2812325 crossref_primary_10_1002_mp_12312 crossref_primary_10_1007_s00268_013_2418_6 crossref_primary_10_1002_cncr_29205 crossref_primary_10_1016_j_soncn_2015_11_005 crossref_primary_10_1188_16_ONF_306_315 crossref_primary_10_18621_eurj_316421 crossref_primary_10_1016_j_jpsychores_2014_07_007 crossref_primary_10_1080_19325037_2018_1473181 crossref_primary_10_4137_CGM_S12769 crossref_primary_10_1016_j_tiv_2020_105000 crossref_primary_10_3389_fcimb_2020_562463 crossref_primary_10_1042_BSR20180479 crossref_primary_10_1016_j_ygyno_2013_06_037 crossref_primary_10_1177_1043454219888805 crossref_primary_10_1007_s00520_015_2832_4 crossref_primary_10_1007_s11936_019_0738_z crossref_primary_10_4081_itjm_2021_1347 crossref_primary_10_3390_molecules27196608 crossref_primary_10_1016_j_ijbiomac_2025_140114 crossref_primary_10_1089_jayao_2016_0064 crossref_primary_10_2196_29579 crossref_primary_10_1148_radiol_15132905 crossref_primary_10_1111_crj_12584 crossref_primary_10_1016_j_jcpo_2021_100293 crossref_primary_10_1016_j_nano_2016_11_016 crossref_primary_10_1016_j_apsb_2023_11_004 crossref_primary_10_1007_s12020_015_0629_3 crossref_primary_10_3928_01477447_20200619_08 crossref_primary_10_1007_s40005_016_0294_4 crossref_primary_10_1155_2019_6726312 crossref_primary_10_3390_md13042010 crossref_primary_10_1016_j_bpa_2013_10_004 crossref_primary_10_1007_s12282_015_0638_3 crossref_primary_10_1016_j_otc_2013_02_004 crossref_primary_10_1080_07347332_2020_1752880 crossref_primary_10_1111_pcmr_12259 crossref_primary_10_1586_era_13_9 crossref_primary_10_1016_j_intimp_2018_04_013 crossref_primary_10_1517_14740338_2015_1014340 crossref_primary_10_3389_fgene_2020_00314 crossref_primary_10_1016_j_ejrad_2014_10_006 crossref_primary_10_1200_JCO_2013_49_1241 crossref_primary_10_1002_clc_22507 crossref_primary_10_1016_j_ygyno_2018_01_010 crossref_primary_10_3390_computers10110137 crossref_primary_10_1155_2016_7276502 crossref_primary_10_3892_ijo_2014_2797 crossref_primary_10_1097_JTO_0000000000000353 crossref_primary_10_1016_j_tranon_2014_11_003 crossref_primary_10_1186_s12885_017_3454_7 crossref_primary_10_1002_ijc_32079 crossref_primary_10_1007_s10620_013_2898_0 crossref_primary_10_1016_j_tranon_2014_11_005 crossref_primary_10_1097_DAD_0000000000000404 crossref_primary_10_1016_j_eurger_2014_02_004 crossref_primary_10_1097_JTO_0000000000000367 crossref_primary_10_1186_s13048_014_0089_z crossref_primary_10_3748_wjg_v20_i46_17648 crossref_primary_10_1002_jcb_29281 crossref_primary_10_1002_jcp_30651 crossref_primary_10_1188_13_ONF_325_336 crossref_primary_10_1007_s11605_014_2645_7 crossref_primary_10_1016_j_jgo_2016_04_006 crossref_primary_10_1093_jjco_hyt196 crossref_primary_10_1371_journal_pone_0123208 crossref_primary_10_1007_s10552_013_0246_5 crossref_primary_10_1111_his_12383 crossref_primary_10_1186_1756_9966_32_15 crossref_primary_10_1089_hum_2016_005 crossref_primary_10_1097_j_pain_0000000000002678 crossref_primary_10_1038_oncsis_2017_39 crossref_primary_10_1586_erv_13_22 crossref_primary_10_1007_s00280_021_04256_8 crossref_primary_10_1016_j_urology_2014_04_023 crossref_primary_10_1245_s10434_013_3170_8 crossref_primary_10_1007_s13187_014_0628_8 crossref_primary_10_1080_13691058_2014_939227 crossref_primary_10_3390_jcm14082705 crossref_primary_10_3390_genes10090640 crossref_primary_10_1038_s41598_017_13495_w crossref_primary_10_1007_s10637_021_01195_2 crossref_primary_10_1177_1077558713510359 crossref_primary_10_1007_s12032_014_0444_3 crossref_primary_10_1155_2022_5794055 crossref_primary_10_1016_j_repc_2021_04_011 crossref_primary_10_1089_jayao_2016_0059 crossref_primary_10_1007_s11010_024_05040_x crossref_primary_10_1016_j_jconrel_2017_10_025 crossref_primary_10_5005_GCSRJ_11042_23109 crossref_primary_10_1007_s13187_015_0903_3 crossref_primary_10_1097_SAP_0000000000000339 crossref_primary_10_1177_1557988314555360 crossref_primary_10_1007_s13402_014_0212_6 crossref_primary_10_1586_14737140_2014_971111 crossref_primary_10_1002_ijc_27994 crossref_primary_10_1016_j_ctrv_2016_06_006 crossref_primary_10_1038_s41598_022_14518_x crossref_primary_10_1002_prca_201500081 crossref_primary_10_1038_npjbcancer_2016_4 crossref_primary_10_1007_s12185_021_03223_6 crossref_primary_10_1097_01_JAA_0000496950_95334_86 crossref_primary_10_1111_cas_12907 crossref_primary_10_1016_j_colsurfb_2018_06_054 crossref_primary_10_3892_ol_2017_7044 crossref_primary_10_1002_cncr_28363 crossref_primary_10_1155_2013_313751 crossref_primary_10_3390_cancers6021111 crossref_primary_10_1200_JCO_2013_51_4802 crossref_primary_10_1038_oncsis_2017_16 crossref_primary_10_1016_j_semcancer_2014_06_006 crossref_primary_10_1371_journal_pntd_0003744 crossref_primary_10_1136_bmjpo_2022_001802 crossref_primary_10_1155_2014_492173 crossref_primary_10_1007_s11596_024_2871_5 crossref_primary_10_2147_CMAR_S301844 crossref_primary_10_1016_j_bmcl_2013_03_048 crossref_primary_10_1158_1541_7786_MCR_13_0467 crossref_primary_10_1177_10781552241266254 crossref_primary_10_3389_fcell_2021_759259 crossref_primary_10_3748_wjg_v22_i42_9288 crossref_primary_10_1007_s12032_012_0353_2 crossref_primary_10_1245_s10434_012_2740_5 crossref_primary_10_1182_blood_2014_07_589911 crossref_primary_10_2217_bmt_15_14 crossref_primary_10_1002_cncr_30274 crossref_primary_10_1093_jpp_rgae150 crossref_primary_10_2217_WHE_14_13 crossref_primary_10_1097_CEJ_0000000000000628 crossref_primary_10_3389_fonc_2022_982461 crossref_primary_10_1016_j_critrevonc_2016_12_003 crossref_primary_10_1016_j_ejca_2016_06_022 crossref_primary_10_1038_srep20616 crossref_primary_10_1371_journal_pone_0076846 crossref_primary_10_1016_j_clgc_2016_08_020 crossref_primary_10_1097_CAD_0000000000000379 crossref_primary_10_1016_j_bbagen_2014_07_018 crossref_primary_10_1016_j_clbc_2019_01_003 crossref_primary_10_1007_s11606_014_3162_9 crossref_primary_10_1007_s12020_015_0580_3 crossref_primary_10_1097_COC_0000000000000313 crossref_primary_10_13181_mji_v27i3_1719 crossref_primary_10_1007_s13534_025_00489_1 crossref_primary_10_1038_srep17435 crossref_primary_10_1002_biot_202000128 crossref_primary_10_1016_j_cca_2014_01_049 crossref_primary_10_1016_j_jcpo_2015_03_001 crossref_primary_10_2217_bmm_2018_0321 crossref_primary_10_4103_jcrt_JCRT_752_20 crossref_primary_10_1097_CEJ_0000000000000602 crossref_primary_10_1097_01893697_201331010_00009 crossref_primary_10_1155_2015_642041 crossref_primary_10_1371_journal_pone_0155242 crossref_primary_10_1039_C6PY00168H crossref_primary_10_2174_0118763863291236240516114419 crossref_primary_10_1056_NEJMe1215300 crossref_primary_10_1016_j_ijpharm_2015_04_028 crossref_primary_10_1007_s00432_018_2823_1 crossref_primary_10_1038_aps_2017_73 crossref_primary_10_1007_s10585_015_9743_0 crossref_primary_10_15829_1560_4071_2021_4703 crossref_primary_10_1007_s00464_019_07197_9 crossref_primary_10_3322_caac_21186 crossref_primary_10_1213_ANE_0000000000004425 crossref_primary_10_1200_JCO_2012_46_6854 crossref_primary_10_3322_caac_21183 crossref_primary_10_1371_journal_pone_0066855 crossref_primary_10_1002_pbc_25096 crossref_primary_10_1111_jdv_13645 crossref_primary_10_1007_s00104_013_2690_x crossref_primary_10_1111_1759_7714_13777 crossref_primary_10_3390_ph15030364 crossref_primary_10_1371_journal_pone_0074473 crossref_primary_10_1097_01893697_201331040_00007 crossref_primary_10_1002_ijc_28669 crossref_primary_10_1007_s00464_016_4987_6 crossref_primary_10_1016_j_jep_2018_03_005 crossref_primary_10_1038_cddis_2017_521 crossref_primary_10_1186_s13765_019_0462_0 crossref_primary_10_1007_s13277_014_2251_z crossref_primary_10_1177_1534735420921439 crossref_primary_10_1038_nrurol_2016_107 crossref_primary_10_1158_1078_0432_CCR_12_2837 crossref_primary_10_1002_pbc_31749 crossref_primary_10_7759_cureus_64217 crossref_primary_10_1089_jayao_2017_0025 crossref_primary_10_2217_fca_15_16 crossref_primary_10_1007_s11764_015_0426_2 crossref_primary_10_1517_13543776_2014_926329 crossref_primary_10_3389_fimmu_2019_01744 crossref_primary_10_1186_s40959_020_0057_2 crossref_primary_10_1016_j_gaitpost_2014_05_015 crossref_primary_10_1007_s00423_016_1432_1 crossref_primary_10_1016_j_bbapap_2013_01_029 crossref_primary_10_1016_j_canlet_2012_11_037 crossref_primary_10_1097_MD_0000000000002611 crossref_primary_10_1111_odi_13157 crossref_primary_10_1080_23294515_2013_877097 crossref_primary_10_3390_ijms24097953 crossref_primary_10_1007_s00428_015_1900_y crossref_primary_10_1038_cgt_2016_80 crossref_primary_10_1002_ijc_29535 crossref_primary_10_5582_bst_2017_01288 crossref_primary_10_3762_bjnano_7_33 crossref_primary_10_1097_CMR_0000000000000137 crossref_primary_10_1016_j_ahj_2019_04_010 crossref_primary_10_1007_s11764_018_0688_6 crossref_primary_10_1016_j_jaad_2014_01_914 crossref_primary_10_1177_10732748221150393 crossref_primary_10_1088_1757_899X_259_1_012006 crossref_primary_10_11124_JBIES_23_00044 crossref_primary_10_1158_0008_5472_CAN_19_3247 crossref_primary_10_1002_ijc_28691 crossref_primary_10_1097_MOU_0b013e32836392bb crossref_primary_10_1080_10810730_2015_1114051 crossref_primary_10_1097_MD_0000000000036819 crossref_primary_10_5966_sctm_2013_0041 crossref_primary_10_1007_s11764_014_0391_1 crossref_primary_10_1002_pros_22878 crossref_primary_10_1007_s13577_021_00582_4 crossref_primary_10_3389_fpsyg_2017_00704 crossref_primary_10_3109_08820139_2014_936445 crossref_primary_10_1038_srep44275 crossref_primary_10_1186_1472_6882_13_230 crossref_primary_10_1097_SLA_0000000000000925 crossref_primary_10_1200_JCO_2014_56_6539 crossref_primary_10_1093_annonc_mdx337 crossref_primary_10_3390_ijms24076615 crossref_primary_10_1517_13543784_2013_842974 crossref_primary_10_1038_s41598_018_28315_y crossref_primary_10_1016_j_bmc_2013_08_057 crossref_primary_10_5301_jbm_5000223 crossref_primary_10_3390_jcm10020323 crossref_primary_10_1097_MD_0000000000021307 crossref_primary_10_3109_01913123_2013_797064 crossref_primary_10_17656_jsmc_10194 crossref_primary_10_1089_jayao_2017_0066 crossref_primary_10_2217_fca_2017_0085 crossref_primary_10_2217_fon_2019_0703 crossref_primary_10_1016_j_conctc_2021_100784 crossref_primary_10_1016_j_canlet_2015_02_039 crossref_primary_10_1038_s41598_018_19568_8 crossref_primary_10_1007_s11033_014_3514_x crossref_primary_10_3389_fgene_2019_01385 crossref_primary_10_1016_j_clinph_2015_07_022 crossref_primary_10_1016_j_biopha_2018_03_085 crossref_primary_10_1111_febs_12902 crossref_primary_10_1007_s12170_016_0517_2 crossref_primary_10_1007_s11912_013_0345_1 crossref_primary_10_3892_or_2016_4685 crossref_primary_10_1111_bph_12401 crossref_primary_10_1016_j_ctrv_2012_11_006 crossref_primary_10_1371_journal_pone_0222035 crossref_primary_10_1177_1010428317705013 crossref_primary_10_3892_ijo_2016_3528 crossref_primary_10_1080_2000656X_2018_1493388 crossref_primary_10_1038_srep22051 crossref_primary_10_2217_hep_15_9 crossref_primary_10_1016_j_abb_2014_07_003 crossref_primary_10_1186_1471_2407_14_446 crossref_primary_10_1016_j_prp_2017_05_002 crossref_primary_10_1089_lgbt_2014_0038 crossref_primary_10_1126_scitranslmed_aau1643 crossref_primary_10_1097_01_JAA_0000451872_86566_bf crossref_primary_10_3892_mmr_2015_4535 crossref_primary_10_1007_s13277_016_5016_z crossref_primary_10_1111_iwj_14367 crossref_primary_10_1007_s11839_013_0401_y crossref_primary_10_1586_14737140_2014_922881 crossref_primary_10_1093_jncics_pky077 crossref_primary_10_1186_s12906_019_2615_4 crossref_primary_10_1245_s10434_015_5006_1 crossref_primary_10_1016_S1470_2045_13_70128_1 crossref_primary_10_1200_JCO_18_02258 crossref_primary_10_1371_journal_pone_0119878 crossref_primary_10_1245_s10434_016_5218_z crossref_primary_10_1016_j_gene_2016_03_012 crossref_primary_10_1186_1472_6882_13_203 crossref_primary_10_3109_0284186X_2013_831471 crossref_primary_10_2217_nnm_13_73 crossref_primary_10_12998_wjcc_v9_i32_9917 crossref_primary_10_4081_ejh_2021_3246 crossref_primary_10_1016_j_ccr_2012_12_020 crossref_primary_10_1186_s12610_018_0082_2 crossref_primary_10_1007_s00044_017_2109_1 crossref_primary_10_1016_j_cpet_2015_07_003 crossref_primary_10_36469_9844 crossref_primary_10_1245_s10434_014_3562_4 crossref_primary_10_1089_thy_2013_0319 crossref_primary_10_1155_2021_5122380 crossref_primary_10_1097_NCC_0000000000000191 crossref_primary_10_1007_s13238_017_0393_7 crossref_primary_10_1007_s10549_017_4365_7 crossref_primary_10_1016_j_ijrobp_2014_02_011 crossref_primary_10_1016_j_rcl_2017_10_008 crossref_primary_10_1186_s12885_016_3040_4 crossref_primary_10_1097_NCC_0000000000000186 crossref_primary_10_1016_j_eururo_2014_08_061 crossref_primary_10_4137_BCBCR_S40693 crossref_primary_10_1016_j_jconrel_2014_01_014 crossref_primary_10_1093_carcin_bgt175 crossref_primary_10_1186_1472_6963_13_314 crossref_primary_10_1111_apm_13168 crossref_primary_10_1016_j_humpath_2013_10_015 crossref_primary_10_1002_jbmr_4539 crossref_primary_10_1177_1740774514525691 crossref_primary_10_1177_08258597231173313 crossref_primary_10_1038_nrurol_2013_274 crossref_primary_10_1111_jcmm_13010 crossref_primary_10_3892_ol_2014_2493 crossref_primary_10_1093_jnci_djt279 crossref_primary_10_1002_pon_3640 crossref_primary_10_1016_j_radonc_2020_04_037 crossref_primary_10_1080_10410236_2020_1724636 crossref_primary_10_1053_j_seminoncol_2014_03_005 crossref_primary_10_1084_jem_20171818 crossref_primary_10_1089_ars_2012_4563 crossref_primary_10_1097_MD_0000000000023574 crossref_primary_10_3390_cancers12040940 crossref_primary_10_1097_MCA_0000000000000429 crossref_primary_10_1007_s12253_016_0067_4 crossref_primary_10_2147_CMAR_S339891 crossref_primary_10_1093_ptj_pzaa002 crossref_primary_10_1016_j_jacc_2014_06_1167 crossref_primary_10_1088_1742_6596_1722_1_012060 crossref_primary_10_3892_mmr_2015_4566 crossref_primary_10_3389_fonc_2019_00825 crossref_primary_10_1016_j_urolonc_2016_07_002 crossref_primary_10_1038_nrdp_2016_96 crossref_primary_10_1159_000511765 crossref_primary_10_1016_j_jacc_2015_04_012 crossref_primary_10_1097_MD_0000000000001333 crossref_primary_10_1007_s11060_018_2880_y crossref_primary_10_1016_j_clbc_2018_10_004 crossref_primary_10_1111_bju_12288 crossref_primary_10_18632_oncotarget_7043 crossref_primary_10_1016_j_clcc_2014_05_001 crossref_primary_10_1161_JAHA_122_025786 crossref_primary_10_1080_07853890_2024_2329132 crossref_primary_10_1007_s11912_015_0445_1 crossref_primary_10_1007_s12032_013_0832_0 crossref_primary_10_1097_MCA_0000000000000444 crossref_primary_10_3389_fimmu_2016_00487 crossref_primary_10_3892_mmr_2016_6056 crossref_primary_10_1007_s13187_015_0876_2 crossref_primary_10_1111_ijn_12747 crossref_primary_10_1158_1078_0432_CCR_18_3032 crossref_primary_10_4103_njcp_njcp_1309_21 crossref_primary_10_1891_1061_3749_27_2_259 crossref_primary_10_1007_s11482_015_9399_6 crossref_primary_10_1007_s00432_021_03753_w crossref_primary_10_1016_j_jsbmb_2019_04_016 crossref_primary_10_1155_2017_9215930 crossref_primary_10_3390_metabo12020110 crossref_primary_10_1080_13557858_2019_1606162 crossref_primary_10_1016_j_pharmthera_2013_05_006 crossref_primary_10_2217_fon_15_71 crossref_primary_10_1038_leu_2017_215 crossref_primary_10_3945_jn_113_177410 crossref_primary_10_1259_bjr_20140018 crossref_primary_10_1186_s12885_017_3968_z crossref_primary_10_1186_s12885_025_14122_y crossref_primary_10_1016_j_humpath_2018_08_007 crossref_primary_10_1007_s00330_020_07673_0 crossref_primary_10_1080_17425247_2016_1208650 crossref_primary_10_1007_s13277_014_2683_5 crossref_primary_10_1038_bjc_2013_361 crossref_primary_10_1016_j_canlet_2019_04_022 crossref_primary_10_1016_j_juro_2014_01_010 crossref_primary_10_3389_fonc_2023_1116999 crossref_primary_10_1148_ryai_2019180014 crossref_primary_10_3389_fonc_2024_1418610 crossref_primary_10_2310_JIM_0b013e318276deb4 crossref_primary_10_1038_bjc_2013_363 crossref_primary_10_1188_14_ONF_E194_E202 crossref_primary_10_3171_2016_9_JNS161585 crossref_primary_10_1007_s10903_022_01358_0 crossref_primary_10_3109_08830185_2013_786711 crossref_primary_10_1371_journal_pone_0216147 crossref_primary_10_1016_j_ejmech_2015_06_040 crossref_primary_10_1016_j_canlet_2020_08_037 crossref_primary_10_1186_s12935_025_03737_7 crossref_primary_10_1016_j_bbcan_2013_01_003 crossref_primary_10_1002_mc_22894 crossref_primary_10_3390_ijms19113356 crossref_primary_10_1016_j_clml_2015_07_640 crossref_primary_10_3390_bioengineering10111271 crossref_primary_10_2217_nnm_2021_0199 crossref_primary_10_2217_WHE_13_55 crossref_primary_10_2217_fon_14_134 crossref_primary_10_3892_ijmm_2015_2326 crossref_primary_10_1007_s13277_016_5021_2 crossref_primary_10_1093_eurheartj_eht512 crossref_primary_10_1007_s10552_013_0252_7 crossref_primary_10_5812_ijcm_80114 crossref_primary_10_3928_00989134_20130808_01 crossref_primary_10_1002_ar_22661 crossref_primary_10_1016_j_mehy_2015_04_018 crossref_primary_10_1177_1010428317695918 crossref_primary_10_3892_ol_2016_5278 crossref_primary_10_1007_s11764_014_0419_6 crossref_primary_10_1002_em_22103 crossref_primary_10_1007_s11596_016_1586_7 crossref_primary_10_1002_jcp_27520 crossref_primary_10_1186_s13098_016_0170_4 crossref_primary_10_1002_cam4_1484 crossref_primary_10_1089_jayao_2019_0170 crossref_primary_10_1002_ejic_201900569 crossref_primary_10_3389_fgene_2019_00930 crossref_primary_10_1007_s12630_014_0170_5 crossref_primary_10_1165_rcmb_2018_0118OC crossref_primary_10_1007_s11886_017_0862_x crossref_primary_10_1097_NCC_0000000000000223 crossref_primary_10_1007_s40291_014_0103_6 crossref_primary_10_1080_14740338_2020_1731471 crossref_primary_10_3389_fonc_2019_00088 crossref_primary_10_1016_j_repce_2016_04_005 crossref_primary_10_1093_jnci_djy152 crossref_primary_10_1016_j_pmrj_2017_05_011 crossref_primary_10_3389_fphy_2020_568206 crossref_primary_10_3390_ijerph19159590 crossref_primary_10_1016_j_prp_2017_12_003 crossref_primary_10_1016_j_gene_2013_10_024 crossref_primary_10_1016_j_jbior_2014_05_002 crossref_primary_10_1007_s00044_015_1456_z crossref_primary_10_3760_cma_j_issn_0366_6999_20123625 crossref_primary_10_1111_cas_13989 crossref_primary_10_1088_1361_6528_aa8791 crossref_primary_10_3892_ol_2013_1449 crossref_primary_10_1111_1440_1681_12420 crossref_primary_10_1111_1475_6773_12148 crossref_primary_10_1371_journal_pone_0101354 crossref_primary_10_1111_cas_13993 crossref_primary_10_3892_mmr_2014_2149 crossref_primary_10_1016_j_canlet_2014_03_011 crossref_primary_10_1016_j_ctrv_2013_01_005 crossref_primary_10_3892_or_2017_5409 crossref_primary_10_1111_pcmr_12110 crossref_primary_10_1007_s42399_023_01607_9 crossref_primary_10_1097_COC_0000000000000285 crossref_primary_10_1245_s10434_015_4849_9 crossref_primary_10_1186_1756_9966_33_25 crossref_primary_10_1111_jcmm_15282 crossref_primary_10_1007_s11764_013_0309_3 crossref_primary_10_1016_j_jchromb_2018_05_050 crossref_primary_10_1016_j_critrevonc_2018_06_014 crossref_primary_10_1007_s11764_014_0365_3 crossref_primary_10_1002_bab_1461 crossref_primary_10_2217_fon_12_129 crossref_primary_10_1007_s11764_015_0431_5 crossref_primary_10_1016_j_juro_2015_11_072 crossref_primary_10_2217_fon_14_173 crossref_primary_10_12998_wjcc_v2_i11_698 crossref_primary_10_1186_s13000_021_01168_2 crossref_primary_10_7759_cureus_81642 crossref_primary_10_1158_0008_5472_CAN_13_3590 crossref_primary_10_1007_s12609_012_0097_1 crossref_primary_10_1245_s10434_017_5896_1 crossref_primary_10_2217_fon_12_115 crossref_primary_10_1038_srep09097 crossref_primary_10_1186_s12885_018_4022_5 crossref_primary_10_3892_or_2013_2661 crossref_primary_10_1111_obr_12321 crossref_primary_10_1016_j_mpmed_2015_03_009 crossref_primary_10_1016_j_ucl_2013_01_013 crossref_primary_10_1093_jscr_rjac630 crossref_primary_10_1016_j_ucl_2013_01_015 crossref_primary_10_1007_s13193_013_0256_5 crossref_primary_10_1177_1535370213489492 crossref_primary_10_1093_jjco_hyt080 crossref_primary_10_1097_TGR_0000000000000083 crossref_primary_10_1002_cncr_29125 crossref_primary_10_1016_j_aogh_2016_10_004 crossref_primary_10_1016_j_jgo_2015_02_004 crossref_primary_10_1002_wrna_1563 crossref_primary_10_2217_bmt_12_63 crossref_primary_10_1021_acs_jmedchem_7b00343 crossref_primary_10_1021_acsbiomaterials_9b01426 crossref_primary_10_1111_jgs_13819 crossref_primary_10_1177_1533033820964238 crossref_primary_10_3389_fcell_2021_745177 crossref_primary_10_1016_j_radonc_2019_08_014 crossref_primary_10_1080_01635581_2015_1055370 crossref_primary_10_5301_ijbm_5000307 crossref_primary_10_5301_ijbm_5000308 crossref_primary_10_1016_j_pec_2016_09_012 crossref_primary_10_1089_ten_teb_2016_0156 crossref_primary_10_1186_1472_6947_14_38 crossref_primary_10_5858_arpa_2013_0039_OA crossref_primary_10_1007_s40265_015_0467_x crossref_primary_10_1016_j_ijpharm_2021_120416 crossref_primary_10_1186_s12935_024_03545_5 crossref_primary_10_1002_cncr_29597 crossref_primary_10_2147_CMAR_S453924 crossref_primary_10_3390_cancers10090303 crossref_primary_10_1016_j_ejso_2015_01_020 crossref_primary_10_1111_his_12264 crossref_primary_10_5888_pcd10_130052 crossref_primary_10_3390_healthcare11233097 crossref_primary_10_1007_s00520_014_2412_z crossref_primary_10_1016_j_ejrad_2014_02_015 crossref_primary_10_1186_s13148_016_0267_5 crossref_primary_10_1016_j_biopha_2017_08_057 crossref_primary_10_1097_COC_0000000000000235 crossref_primary_10_3389_fmed_2019_00233 crossref_primary_10_1515_pac_2023_1111 crossref_primary_10_1016_j_ejso_2018_11_001 crossref_primary_10_1111_jgh_15657 crossref_primary_10_1007_s11764_014_0392_0 crossref_primary_10_1007_s11764_013_0336_0 crossref_primary_10_1016_j_jshs_2019_04_002 crossref_primary_10_3390_jcm10215072 crossref_primary_10_2147_CMAR_S482484 crossref_primary_10_1016_j_suronc_2024_102046 crossref_primary_10_3390_pharmaceutics14050929 crossref_primary_10_3109_1061186X_2013_833207 crossref_primary_10_7453_gahmj_2013_046 crossref_primary_10_3748_wjg_v20_i44_16480 crossref_primary_10_1016_j_trsl_2015_01_005 crossref_primary_10_2147_BCTT_S366530 crossref_primary_10_1002_clc_23966 crossref_primary_10_1007_s11055_021_01066_6 crossref_primary_10_1080_2162402X_2015_1029698 crossref_primary_10_1080_13607863_2014_892567 crossref_primary_10_1097_j_pain_0000000000000108 crossref_primary_10_1159_000365950 crossref_primary_10_1002_cam4_1813 crossref_primary_10_1093_carcin_bgac087 crossref_primary_10_1188_13_ONF_575_580 crossref_primary_10_1002_ange_202218613 crossref_primary_10_3390_life12020291 crossref_primary_10_1007_s10549_022_06715_z crossref_primary_10_1155_2014_974309 crossref_primary_10_1186_s12943_017_0682_z crossref_primary_10_3389_fmed_2021_585483 crossref_primary_10_5534_wjmh_180061 crossref_primary_10_1016_j_clinimag_2022_06_008 crossref_primary_10_1080_09553002_2021_1864497 crossref_primary_10_3892_ijo_2013_1810 crossref_primary_10_2217_fon_2017_2500 crossref_primary_10_1186_s12935_017_0410_1 crossref_primary_10_1371_journal_pone_0072373 crossref_primary_10_2217_bmm_13_127 crossref_primary_10_1016_j_cllc_2024_07_014 crossref_primary_10_1002_cncr_29150 crossref_primary_10_3390_cancers11020209 crossref_primary_10_1038_bjc_2014_196 crossref_primary_10_1097_01_j_pain_0000460319_87643_11 crossref_primary_10_1007_s10549_017_4516_x crossref_primary_10_1016_j_neo_2015_08_005 crossref_primary_10_3390_cancers13194847 crossref_primary_10_1097_MD_0000000000014180 crossref_primary_10_1089_thy_2016_0626 crossref_primary_10_1007_s13277_015_3194_8 crossref_primary_10_3390_ph8010001 crossref_primary_10_1039_C5AN02322J crossref_primary_10_1111_ans_12889 crossref_primary_10_1016_j_molonc_2014_06_012 crossref_primary_10_1016_j_lungcan_2013_03_019 crossref_primary_10_1016_j_oraloncology_2019_01_010 crossref_primary_10_1245_s10434_018_6496_4 crossref_primary_10_1002_jso_25017 crossref_primary_10_1038_gt_2016_5 crossref_primary_10_2215_CJN_09980912 crossref_primary_10_1016_j_jgo_2023_101532 crossref_primary_10_1016_j_ejmech_2017_07_028 crossref_primary_10_1007_s00520_016_3322_z crossref_primary_10_1177_00914150211024174 crossref_primary_10_1111_iwj_13899 crossref_primary_10_1007_s11894_013_0357_x crossref_primary_10_1016_j_repc_2016_04_006 crossref_primary_10_1016_j_micromeso_2020_110228 crossref_primary_10_1007_s11764_014_0383_1 crossref_primary_10_1371_journal_pone_0065614 crossref_primary_10_3892_ijo_2015_3270 crossref_primary_10_1007_s11899_016_0331_4 crossref_primary_10_1148_radiol_13122833 crossref_primary_10_1667_RR14864_1 crossref_primary_10_7603_s40681_015_0002_0 crossref_primary_10_1016_j_bcp_2015_07_008 crossref_primary_10_1111_jcmm_12889 crossref_primary_10_1016_j_clgc_2016_11_006 crossref_primary_10_1002_cam4_791 crossref_primary_10_1002_cbin_10376 crossref_primary_10_1080_15384101_2018_1469873 crossref_primary_10_1016_j_soncn_2017_02_006 crossref_primary_10_1007_s00520_022_07532_2 crossref_primary_10_1038_nrc3397 crossref_primary_10_1007_s40256_018_0286_z crossref_primary_10_1007_s00520_024_09070_5 crossref_primary_10_1016_j_gene_2018_02_065 crossref_primary_10_1007_s11051_014_2682_x crossref_primary_10_2217_ahe_13_33 crossref_primary_10_1002_cncr_29076 crossref_primary_10_1007_s11307_023_01823_8 crossref_primary_10_1002_cam4_315 crossref_primary_10_1007_s13277_014_3019_1 crossref_primary_10_1007_s13277_015_3667_9 crossref_primary_10_1186_1471_2407_13_595 crossref_primary_10_1016_j_clbc_2019_11_003 crossref_primary_10_3389_fphar_2024_1472387 crossref_primary_10_1186_s12951_019_0508_9 crossref_primary_10_1002_cncr_31393 crossref_primary_10_1089_gtmb_2013_0386 crossref_primary_10_1080_07357907_2019_1575969 crossref_primary_10_1007_s41971_021_00091_z crossref_primary_10_1016_j_saa_2014_04_147 crossref_primary_10_1016_j_arcmed_2016_12_005 crossref_primary_10_1093_jncics_pkac021 crossref_primary_10_1155_2020_4258035 crossref_primary_10_1177_0300985815571680 crossref_primary_10_3171_2021_2_SPINE202027 crossref_primary_10_1007_s10552_015_0659_4 crossref_primary_10_3892_mmr_2017_6468 crossref_primary_10_1371_journal_pone_0194609 crossref_primary_10_1016_S1470_2045_12_70472_2 crossref_primary_10_1371_journal_pone_0096141 crossref_primary_10_1016_j_leukres_2013_08_002 crossref_primary_10_1177_1062860614537676 crossref_primary_10_1007_s10044_016_0574_7 crossref_primary_10_1002_cncr_29056 crossref_primary_10_1016_j_cllc_2015_06_004 crossref_primary_10_1016_j_jsbmb_2014_08_016 crossref_primary_10_1093_jnci_dju232 crossref_primary_10_1177_0300060514566649 crossref_primary_10_3389_fphar_2024_1404692 crossref_primary_10_1111_his_12686 crossref_primary_10_1155_2014_210560 crossref_primary_10_5812_ijcm_61165 crossref_primary_10_1002_pon_3751 crossref_primary_10_1007_s13277_013_1471_y crossref_primary_10_1097_MD_0000000000018089 crossref_primary_10_1038_s41419_019_1508_2 crossref_primary_10_1007_s10330_015_0083_y crossref_primary_10_3389_fonc_2020_531131 crossref_primary_10_1099_jmm_0_048975_0 crossref_primary_10_1097_MPA_0b013e318279c577 crossref_primary_10_1249_MSS_0000000000000160 crossref_primary_10_1016_j_canep_2022_102160 crossref_primary_10_1038_ncomms7879 crossref_primary_10_1161_CIRCULATIONAHA_114_013777 crossref_primary_10_1016_j_biopha_2017_12_092 crossref_primary_10_3389_fcell_2021_647387 crossref_primary_10_1089_end_2013_0051 crossref_primary_10_1016_j_actbio_2015_02_009 crossref_primary_10_1155_2014_540463 crossref_primary_10_1038_bjc_2015_334 crossref_primary_10_1016_j_semcancer_2022_06_010 crossref_primary_10_1158_0008_5472_CAN_15_1208 crossref_primary_10_1016_j_kjms_2015_09_003 crossref_primary_10_1016_j_prp_2018_08_015 crossref_primary_10_3390_ijms23042053 crossref_primary_10_1002_ajh_23688 crossref_primary_10_1007_s13187_016_1064_8 crossref_primary_10_1177_1060028013518899 crossref_primary_10_1245_s10434_018_6465_y crossref_primary_10_1016_j_ebiom_2016_08_029 crossref_primary_10_1186_s13012_014_0167_z crossref_primary_10_1016_j_jmbbm_2025_107109 crossref_primary_10_1097_HNP_0000000000000198 crossref_primary_10_1080_14737140_2019_1699065 crossref_primary_10_1186_1471_2407_14_387 crossref_primary_10_1007_s10549_015_3595_9 crossref_primary_10_1002_ijc_28593 crossref_primary_10_3892_ijo_2014_2495 crossref_primary_10_3109_1061186X_2013_837469 crossref_primary_10_1177_2151458516658330 crossref_primary_10_1002_pon_3704 crossref_primary_10_3892_mmr_2014_2801 crossref_primary_10_1007_s13193_018_0731_0 crossref_primary_10_1186_s40463_021_00506_0 crossref_primary_10_2147_OTT_S238338 crossref_primary_10_1016_j_jsbmb_2015_04_018 crossref_primary_10_1097_SMJ_0000000000000022 crossref_primary_10_5306_wjco_v5_i3_263 crossref_primary_10_1002_cjp2_116 crossref_primary_10_1186_1471_2407_14_373 crossref_primary_10_1016_j_bjorl_2018_12_001 crossref_primary_10_1016_j_eururo_2013_02_036 crossref_primary_10_1093_ejcts_ezt031 crossref_primary_10_3322_caac_21234 crossref_primary_10_1200_JGO_2015_001974 crossref_primary_10_1016_j_hrcr_2016_04_009 crossref_primary_10_1016_j_jgo_2014_11_003 crossref_primary_10_1186_1472_6963_13_93 crossref_primary_10_1097_01_REO_0000000000000220 crossref_primary_10_3348_kjr_2024_0208 crossref_primary_10_1007_s10637_020_00948_9 crossref_primary_10_1007_s12254_013_0088_6 crossref_primary_10_1007_s13577_023_00895_6 crossref_primary_10_3322_caac_21220 crossref_primary_10_1586_eem_13_5 crossref_primary_10_1038_srep30599 crossref_primary_10_1016_j_clinimag_2020_07_005 crossref_primary_10_1007_s11596_020_2189_x crossref_primary_10_1155_2017_1529564 crossref_primary_10_1002_jcb_28984 crossref_primary_10_1097_NCC_0000000000000096 crossref_primary_10_1158_1541_7786_MCR_15_0048 crossref_primary_10_1111_1759_7714_13018 crossref_primary_10_1177_1541931214581169 crossref_primary_10_1111_cpr_12098 crossref_primary_10_1016_j_cjca_2016_05_001 crossref_primary_10_1002_iub_1361 crossref_primary_10_1089_jpm_2015_0133 crossref_primary_10_1007_s13277_015_4020_z crossref_primary_10_3389_fphar_2022_854592 crossref_primary_10_1111_1467_9566_12303 crossref_primary_10_3390_ijms241310951 crossref_primary_10_1007_s11556_012_0114_4 crossref_primary_10_1007_s10549_019_05363_0 crossref_primary_10_2147_IJGM_S338250 crossref_primary_10_3109_10428194_2014_898758 crossref_primary_10_1371_journal_pone_0070826 crossref_primary_10_1186_s12906_018_2208_7 crossref_primary_10_3389_fphar_2020_01055 crossref_primary_10_1088_1748_605X_aa8c51 crossref_primary_10_1158_0008_5472_CAN_18_2486 crossref_primary_10_1016_j_prp_2015_08_004 crossref_primary_10_3390_ijms15059103 crossref_primary_10_1007_s11547_018_0950_z crossref_primary_10_1111_cas_13692 crossref_primary_10_1007_s12609_013_0113_0 crossref_primary_10_1007_s12094_015_1297_8 crossref_primary_10_1016_j_biomaterials_2013_03_006 crossref_primary_10_1016_j_nano_2019_02_021 crossref_primary_10_1038_s41416_019_0383_z crossref_primary_10_1097_MD_0000000000033297 crossref_primary_10_1136_jclinpath_2014_202658 crossref_primary_10_1016_j_cej_2023_142371 crossref_primary_10_1007_s00405_014_3104_5 crossref_primary_10_1016_j_urolonc_2013_10_005 crossref_primary_10_1371_journal_pone_0138049 crossref_primary_10_1517_17425255_2013_802771 crossref_primary_10_1186_s12967_015_0637_3 crossref_primary_10_3748_wjg_v22_i22_5193 crossref_primary_10_1016_j_bbabio_2012_10_015 crossref_primary_10_1002_jcb_26312 crossref_primary_10_1007_s00520_023_08140_4 crossref_primary_10_1097_MPA_0000000000000218 crossref_primary_10_3389_fonc_2014_00104 crossref_primary_10_1007_s00018_020_03666_w crossref_primary_10_1016_j_bbcan_2014_09_002 crossref_primary_10_1016_j_ygyno_2015_01_552 crossref_primary_10_3390_ijms131013414 crossref_primary_10_1371_journal_pone_0184412 crossref_primary_10_1016_j_ebiom_2016_06_023 crossref_primary_10_2217_fon_2021_1530 crossref_primary_10_1053_j_jvca_2017_05_016 crossref_primary_10_1186_1471_2407_14_767 crossref_primary_10_1007_s00520_023_07936_8 crossref_primary_10_1007_s00520_016_3229_8 crossref_primary_10_1371_journal_pone_0093997 crossref_primary_10_1016_j_ejmech_2017_03_037 crossref_primary_10_1080_07391102_2017_1323013 crossref_primary_10_1186_s12935_017_0460_4 crossref_primary_10_1093_jnci_dju242 crossref_primary_10_1158_0008_5472_CAN_15_2932 crossref_primary_10_1080_15384101_2019_1678966 crossref_primary_10_1371_journal_pone_0090002 crossref_primary_10_12998_wjcc_v7_i12_1492 crossref_primary_10_3390_catal14120840 crossref_primary_10_1016_j_jclinepi_2015_01_013 crossref_primary_10_1007_s10549_013_2641_8 crossref_primary_10_3390_molecules19033193 crossref_primary_10_1007_s13187_014_0785_9 crossref_primary_10_1177_107327481402100106 crossref_primary_10_1016_j_yexmp_2017_02_009 crossref_primary_10_1007_s10880_018_9547_x crossref_primary_10_1007_s11255_024_04116_3 crossref_primary_10_1371_journal_pone_0105570 crossref_primary_10_3892_ijo_2018_4502 crossref_primary_10_1038_cddis_2013_333 crossref_primary_10_1186_s12943_016_0555_x crossref_primary_10_4103_0973_1482_163683 crossref_primary_10_1111_jcmm_14208 crossref_primary_10_1007_s11864_013_0265_1 crossref_primary_10_3390_ijms140713958 crossref_primary_10_3103_S0095452723010036 crossref_primary_10_1002_pon_3783 crossref_primary_10_1007_s11936_014_0296_3 crossref_primary_10_3109_10428194_2015_1075019 crossref_primary_10_1016_j_leukres_2017_01_023 crossref_primary_10_1158_0008_5472_CAN_15_2951 crossref_primary_10_3727_096504016X14648701447814 crossref_primary_10_1080_17474124_2017_1264269 crossref_primary_10_1007_s00432_023_05553_w crossref_primary_10_1186_s13048_018_0442_8 crossref_primary_10_1007_s10555_012_9410_8 crossref_primary_10_1111_jocn_13125 crossref_primary_10_1093_sxmrev_qead021 crossref_primary_10_1097_CMR_0000000000000456 crossref_primary_10_3892_ol_2013_1710 crossref_primary_10_1148_radiol_2018171139 crossref_primary_10_1109_ACCESS_2023_3340677 crossref_primary_10_5812_ijcm_84627 crossref_primary_10_1088_0031_9155_61_21_R344 crossref_primary_10_1684_bdc_2014_2023 crossref_primary_10_1038_bjc_2015_68 crossref_primary_10_1016_j_canep_2023_102406 crossref_primary_10_1080_2162402X_2016_1214790 crossref_primary_10_1007_s10585_014_9638_5 crossref_primary_10_1097_MOG_0000000000000321 crossref_primary_10_1007_s00520_014_2306_0 crossref_primary_10_1038_s41598_017_13320_4 crossref_primary_10_1124_jpet_114_218644 crossref_primary_10_1007_s12094_021_02672_z crossref_primary_10_1007_s12274_016_1328_y crossref_primary_10_3389_fonc_2014_00171 crossref_primary_10_17826_cumj_1324675 crossref_primary_10_2196_56939 crossref_primary_10_1186_s12885_022_09460_0 crossref_primary_10_1016_j_ijge_2017_11_001 crossref_primary_10_1007_s13277_014_2223_3 crossref_primary_10_2217_lmt_13_14 crossref_primary_10_1016_j_ygyno_2013_05_022 crossref_primary_10_1016_j_ejso_2017_11_026 crossref_primary_10_3390_ijms14059514 crossref_primary_10_2478_bjmg_2018_0022 crossref_primary_10_1158_1541_7786_MCR_17_0458 crossref_primary_10_1517_14728222_2014_882323 crossref_primary_10_1007_s11596_016_1585_8 crossref_primary_10_1186_s12906_024_04673_1 crossref_primary_10_1089_jayao_2015_0049 crossref_primary_10_1007_s12253_014_9883_6 crossref_primary_10_3892_etm_2017_4343 crossref_primary_10_3390_app11156910 crossref_primary_10_6061_clinics_2013_05_12 crossref_primary_10_1007_s00432_014_1735_y crossref_primary_10_1080_10286020_2019_1588888 crossref_primary_10_1038_nrclinonc_2013_41 crossref_primary_10_1007_s00520_013_2107_x crossref_primary_10_1016_j_gene_2013_03_037 crossref_primary_10_1590_0100_6991e_20202698 crossref_primary_10_1007_s10405_016_0048_z crossref_primary_10_1016_j_amepre_2013_10_030 crossref_primary_10_2217_fon_13_249 crossref_primary_10_1007_s13277_015_4745_8 crossref_primary_10_1007_s13277_014_2791_2 crossref_primary_10_4103_jcrt_JCRT_892_18 crossref_primary_10_3389_fcvm_2021_763469 crossref_primary_10_1016_j_canlet_2017_08_014 crossref_primary_10_1016_j_tjog_2013_05_005 crossref_primary_10_1002_jso_23312 crossref_primary_10_1136_bmjopen_2014_006851 crossref_primary_10_1007_s00198_013_2331_8 crossref_primary_10_1007_s11764_014_0351_9 crossref_primary_10_1177_1534735416639714 crossref_primary_10_1002_med_21463 crossref_primary_10_1007_s13277_015_4691_5 crossref_primary_10_1111_cas_12741 crossref_primary_10_3390_ijms24087495 crossref_primary_10_1016_j_clml_2014_08_003 crossref_primary_10_1111_imj_13305 crossref_primary_10_3389_fonc_2014_00182 crossref_primary_10_3892_mmr_2014_2438 crossref_primary_10_1016_j_jgo_2019_01_010 crossref_primary_10_3233_CBM_170711 crossref_primary_10_1007_s00044_017_2082_8 crossref_primary_10_3390_biom12091185 crossref_primary_10_1007_s12170_014_0414_5 crossref_primary_10_1016_j_jacr_2013_05_006 crossref_primary_10_2217_pmt_14_20 crossref_primary_10_1007_s12013_014_0036_z crossref_primary_10_1016_j_canlet_2013_02_043 crossref_primary_10_1016_S1470_2045_12_70424_2 crossref_primary_10_1097_MLR_0000000000000943 crossref_primary_10_3389_fcell_2021_666857 crossref_primary_10_1177_1359105316650930 crossref_primary_10_1097_CM9_0000000000000156 crossref_primary_10_1371_journal_pone_0073985 crossref_primary_10_1371_journal_pone_0094441 crossref_primary_10_5306_wjco_v8_i1_1 crossref_primary_10_3390_antiox8040103 crossref_primary_10_1080_14756366_2019_1612889 crossref_primary_10_3389_fonc_2014_00120 crossref_primary_10_3390_ijms17050718 crossref_primary_10_1371_journal_pone_0085508 crossref_primary_10_1007_s00432_013_1491_4 crossref_primary_10_1089_jayao_2018_0128 crossref_primary_10_1002_adfm_201300793 crossref_primary_10_1016_j_amjsurg_2024_115830 crossref_primary_10_1038_bjc_2013_670 crossref_primary_10_61186_jcc_5_2_3 crossref_primary_10_1016_j_pdpdt_2024_104057 crossref_primary_10_1371_journal_pone_0115415 crossref_primary_10_1016_j_colsurfb_2014_10_028 crossref_primary_10_1002_jps_23356 crossref_primary_10_1111_ans_15637 crossref_primary_10_1097_COC_0000000000000153 crossref_primary_10_1016_j_chembiol_2015_12_003 crossref_primary_10_1016_j_molonc_2013_02_005 crossref_primary_10_2217_cer_14_67 crossref_primary_10_1016_j_ctrv_2014_04_003 crossref_primary_10_1111_bph_13196 crossref_primary_10_1038_srep11062 crossref_primary_10_3389_fendo_2014_00213 crossref_primary_10_1080_0092623X_2013_842194 crossref_primary_10_1111_febs_14773 crossref_primary_10_1142_S1088424619300118 crossref_primary_10_1177_1534735416645181 crossref_primary_10_1371_journal_pone_0090062 crossref_primary_10_5435_JAAOS_D_18_00491 crossref_primary_10_1186_1477_7819_11_236 crossref_primary_10_1371_journal_pone_0183074 crossref_primary_10_1007_s12672_023_00643_0 crossref_primary_10_3389_fonc_2014_00143 crossref_primary_10_1007_s00280_014_2570_1 crossref_primary_10_1186_1748_717X_9_28 crossref_primary_10_1016_j_lungcan_2020_07_015 crossref_primary_10_1159_000445365 crossref_primary_10_1177_1078155220959414 crossref_primary_10_1016_j_hlc_2024_01_013 crossref_primary_10_1007_s00345_012_0958_2 crossref_primary_10_3109_09638288_2013_802378 crossref_primary_10_1517_17425247_2015_978760 crossref_primary_10_1038_srep12379 crossref_primary_10_1016_j_febslet_2015_06_037 crossref_primary_10_2217_bmt_13_28 crossref_primary_10_1038_s41389_018_0086_y crossref_primary_10_1210_jc_2014_3039 crossref_primary_10_1016_j_eujim_2018_08_007 crossref_primary_10_2147_CLEP_S484797 crossref_primary_10_1161_JAHA_115_001779 crossref_primary_10_1177_1534735418766615 crossref_primary_10_5306_wjco_v5_i2_86 crossref_primary_10_1016_j_ejon_2022_102174 crossref_primary_10_1002_cncr_29488 crossref_primary_10_1371_journal_pone_0103847 crossref_primary_10_3389_fonc_2018_00146 crossref_primary_10_1016_j_urology_2016_08_035 crossref_primary_10_1016_j_ctarc_2021_100373 crossref_primary_10_2217_fon_2020_0073 crossref_primary_10_1155_2013_262313 crossref_primary_10_4155_fmc_2023_0351 crossref_primary_10_1002_ejhf_654 crossref_primary_10_1371_journal_pone_0072210 crossref_primary_10_1016_j_bjp_2016_04_003 crossref_primary_10_1016_j_ejrnm_2016_03_002 crossref_primary_10_1038_s41598_017_02256_4 crossref_primary_10_1002_pi_5072 crossref_primary_10_1016_j_critrevonc_2014_10_014 crossref_primary_10_1039_C4NR07139E crossref_primary_10_1096_fj_201802067RR crossref_primary_10_1158_1078_0432_CCR_13_1887 crossref_primary_10_1007_s00520_019_04873_3 crossref_primary_10_1002_pbc_27304 crossref_primary_10_5301_jbm_5000144 crossref_primary_10_7314_APJCP_2015_16_9_3605 crossref_primary_10_1007_s12312_018_0389_0 crossref_primary_10_3892_etm_2016_3713 crossref_primary_10_5761_atcs_oa_18_00027 crossref_primary_10_1188_15_ONF_E358_E367 crossref_primary_10_1016_j_lungcan_2017_01_003 crossref_primary_10_1089_end_2013_0475 crossref_primary_10_1186_s12967_015_0455_7 crossref_primary_10_3892_ijo_2014_2574 crossref_primary_10_1007_s13277_012_0560_7 crossref_primary_10_3390_ijms24010103 crossref_primary_10_1038_s41467_020_16777_6 crossref_primary_10_1188_13_CJON_E63_E67 crossref_primary_10_1158_1078_0432_CCR_13_1434 crossref_primary_10_1186_s13014_022_02131_1 crossref_primary_10_1158_1078_0432_CCR_16_1023 crossref_primary_10_1002_jcp_27240 crossref_primary_10_1007_s11136_020_02683_3 crossref_primary_10_1245_s10434_024_15577_2 crossref_primary_10_1186_1479_5876_11_38 crossref_primary_10_1158_0008_5472_CAN_14_2305 crossref_primary_10_1093_aje_kws580 crossref_primary_10_3390_jcm7100303 crossref_primary_10_1016_j_bbrc_2015_11_093 crossref_primary_10_1080_07347332_2017_1357665 crossref_primary_10_1016_j_apmr_2017_06_016 crossref_primary_10_1080_07347332_2013_874004 crossref_primary_10_1160_TH13_03_0206 crossref_primary_10_1016_j_sajb_2023_01_013 crossref_primary_10_1016_j_mam_2015_06_002 crossref_primary_10_3389_fonc_2021_627504 crossref_primary_10_1007_s12032_013_0781_7 crossref_primary_10_1186_s13148_018_0533_9 crossref_primary_10_1053_j_gastro_2015_07_050 crossref_primary_10_1016_j_bmc_2018_09_001 crossref_primary_10_1007_s11030_020_10093_3 crossref_primary_10_1002_cncr_29040 crossref_primary_10_1016_j_bbrc_2018_09_073 crossref_primary_10_1007_s00520_014_2346_5 crossref_primary_10_1097_CAD_0000000000000144 crossref_primary_10_1002_jcb_25950 crossref_primary_10_1136_bmjopen_2017_018070 crossref_primary_10_3389_fgene_2022_1017539 crossref_primary_10_1007_s00432_022_04148_1 crossref_primary_10_1002_pon_4182 crossref_primary_10_1016_j_lungcan_2016_08_002 crossref_primary_10_1038_s41467_021_26367_9 crossref_primary_10_1016_j_clbc_2017_12_002 crossref_primary_10_1371_journal_pone_0160836 crossref_primary_10_1007_s12032_014_0104_7 crossref_primary_10_3390_polym13132025 crossref_primary_10_1158_0008_5472_CAN_12_3313 crossref_primary_10_1159_000499569 crossref_primary_10_1245_s10434_024_15982_7 crossref_primary_10_1016_j_eururo_2013_08_006 crossref_primary_10_3390_molecules22020240 crossref_primary_10_3390_cancers14051218 crossref_primary_10_1007_s12094_014_1210_x crossref_primary_10_2217_crc_15_21 crossref_primary_10_1016_j_wjam_2019_08_005 crossref_primary_10_1002_ardp_202200123 crossref_primary_10_1016_S0140_6736_13_61649_9 crossref_primary_10_1007_s12010_015_1608_0 crossref_primary_10_1200_JCO_2014_55_0707 crossref_primary_10_1177_1753465815589698 crossref_primary_10_1177_2042098614529603 crossref_primary_10_1007_s10549_019_05197_w crossref_primary_10_1002_acm2_14614 crossref_primary_10_1002_cncr_29014 crossref_primary_10_1038_bjc_2013_250 crossref_primary_10_1007_s12094_013_1055_8 crossref_primary_10_1007_s00280_018_3579_7 crossref_primary_10_1016_j_pec_2013_04_002 crossref_primary_10_1007_s00520_015_2994_0 crossref_primary_10_1007_s11764_014_0360_8
Cites_doi	10.1016/j.ejca.2010.06.010 10.1002/cncr.22598 10.1001/jama.295.18.2164 10.1158/1055-9965.EPI-07-2541 10.1093/jnci/djq495 10.1002/1099-1611(200005/06)9:3<232::AID-PON458>3.0.CO;2-J 10.1158/1055-9965.EPI-10-0988 10.3322/canjclin.56.5.254 10.1136/bmj.b5569 10.3322/caac.20081 10.1634/theoncologist.12-S1-52 10.1200/JCO.2005.07.024 10.1007/BF01681961 10.1016/0360-3016(94)00656-6 10.1016/j.ejca.2005.05.017 10.1002/cncr.25681 10.1182/asheducation-2005.1.523 10.1093/acprof:oso/9780195149616.003.0044 10.1037/0278-6133.26.6.660 10.1200/JCO.2004.08.094 10.1002/cncr.24363 10.1200/JCO.2008.21.2613 10.1016/S0885-3924(00)00144-5 10.1002/cncr.11149 10.1002/cncr.22556 10.1210/jcem.87.8.8782 10.1200/JCO.2003.02.053 10.1053/j.seminoncol.2003.08.007 10.1089/thy.2010.0021 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B 10.1002/pon.657 10.1097/00005392-200102000-00019 10.6004/jnccn.2010.0067 10.1001/jama.293.17.2095 10.1001/archinte.165.5.552 10.1200/JCO.2004.00.3996 10.1097/01.sla.0000197738.63512.23 10.1097/00006842-200207000-00010 10.1016/S0885-3924(02)00388-3 10.1200/JCO.1998.16.2.501 10.1001/jama.1991.03470120074036 10.1016/S0901-5027(03)90399-1 10.1200/JCO.2008.21.7018 10.1056/NEJM198907203210302 10.1177/107327489900600304 10.1097/PSY.0b013e3180417cf4 10.1200/JCO.2003.04.093 10.1136/bmj.38111.639734.7C 10.1207/S15324796ABM2501_03 10.1016/S0090-4295(02)01579-0 10.1158/1940-6207.CAPR-11-0098 10.1056/NEJMoa021423 10.1007/s10552-011-9761-4 10.1592/phco.28.12.1511 10.1016/j.jpainsymman.2010.06.020 10.1056/NEJMra0801454 10.1016/S1470-2045(04)01463-9 10.1016/S0022-5347(17)51695-X 10.1158/1055-9965.EPI-10-0299 10.1016/j.soncn.2008.05.005 10.1001/jama.295.4.387 10.1097/01.ju.0000091993.73842.9b 10.1002/pon.569 10.1056/NEJMoa041943 10.1002/cncr.10245 10.1002/cncr.11742 10.1007/s10552-006-0072-0 10.1200/JCO.2005.04.916 10.1056/NEJMoa050518 10.1080/08870440310001606507 10.1002/ijc.10981 10.1001/jama.2009.1348 10.1093/gerona/58.1.M82 10.1016/S1470-2045(09)70228-1 10.1200/JCO.2003.01.119 10.1002/cncr.10978 10.1093/jnci/94.1.39 10.1007/s11136-006-9138-4 10.1002/cncr.20529 10.1007/s10549-006-9479-2 10.1158/1055-9965.EPI-08-0960 10.1200/JCO.2002.20.2.485 10.1002/lary.21076 10.1007/s005200000165 10.1080/1354850021000059250 10.1016/S0022-5347(17)53725-8 10.1200/JCO.2000.18.7.1570 10.3949/ccjm.75.7.531 10.1016/j.semradonc.2007.02.004 10.1053/j.seminoncol.2003.08.025 10.1016/S0022-5347(05)68000-7 10.1177/1557988309356101 10.1002/1097-0142(20010915)92:6 <1689::AID-CNCR1498>3.0.CO;2-H 10.1016/j.breast.2007.07.027 10.1097/00005650-199308000-00006 10.1073/pnas.132253599 10.2165/11595820-000000000-00000 10.1002/pon.1074 10.1158/1055-9965.EPI-11-0611 10.1016/S0277-9536(99)00281-6 10.3322/caac.20001 10.1200/JCO.2004.01.120 10.1634/theoncologist.12-S1-4 10.1002/cncr.27405 10.1200/JCO.2002.10.085 10.1200/JCO.2011.39.4288 10.1002/sim.1304 10.1016/S1470-2045(11)70002-X 10.1097/PRS.0b013e3181f958de 10.6004/jnccn.2009.0076 10.1200/JCO.2010.27.9752 10.1002/pon.1703 10.1200/JCO.2011.35.9729 10.1200/JCO.2003.08.163 10.1002/cncr.21488 10.1016/j.critrevonc.2008.01.008 10.1002/pon.1049 10.1093/jnci/djg0019 10.1016/S0959-8049(03)00545-8 10.1023/B:BREA.0000003916.39959.73 10.1037/0278-6133.23.6.595 10.1056/NEJM198507253130421 10.1093/annonc/mdm056 10.3322/canjclin.57.4.242 10.1002/cncr.20714 10.1056/NEJMsa060185 10.1200/JOP.0912001 10.1002/cncr.11253 10.1634/theoncologist.11-2-96 10.1093/jnci/djj130 10.1002/pon.1546 10.1007/s10549-007-9831-1 10.1200/JCO.2008.20.2267 10.1207/s15324796abm2903_10 10.1056/NEJMoa1102873 10.1016/S0167-8140(00)00166-3 10.3322/caac.20140 10.1200/JCO.1998.16.5.1689 10.1002/ijc.22827 10.1002/ana.410430511 10.1080/00926230490258884 10.1002/cncr.22189 10.1081/CNV-100107743 10.1200/JCO.2009.26.9324 10.1002/cncr.25761 10.1002/cncr.22058 10.1200/JCO.2009.27.2427 10.1002/cncr.20272 10.1093/jnci/djr322 10.1007/s11136-011-9953-0 10.1007/s00520-006-0207-6 10.1056/NEJMoa0900386 10.3322/caac.20040 10.1001/jama.2011.1139 10.1016/S0885-3924(03)00218-5 10.1038/sj.bjc.6602677 10.1038/nrcardio.2010.121 10.1016/j.eururo.2011.11.010 10.1001/jama.2010.258 10.1002/cncr.24588 10.1097/AOG.0b013e3181f87c4b 10.1097/01.coc.0000156922.58631.d7 10.1097/00002820-198106000-00004 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9 10.1097/PPO.0b013e31818daeee
ContentType	Journal Article
Copyright	Published 2012 American Cancer Society, Inc. Copyright Lippincott Williams & Wilkins Jul/Aug 2012
Copyright_xml	– notice: Published 2012 American Cancer Society, Inc. – notice: Copyright Lippincott Williams & Wilkins Jul/Aug 2012
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U RC3 7X8
DOI	10.3322/caac.21149
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & allied health premium. Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Research Library Research Library (Corporate) ProQuest Nursing and Allied Health Premium Biotechnology and BioEngineering Abstracts Research Library China ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) Research Library China ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Research Library Prep MEDLINE - Academic CrossRef MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Statistics
EISSN	1542-4863
EndPage	241
ExternalDocumentID	2708579281 22700443 10_3322_caac_21149 CAAC21149
Genre	article Journal Article Review Feature
GeographicLocations	United States United States--US
GeographicLocations_xml	– name: United States – name: United States--US
GroupedDBID	.GA .GJ .Y3 0R~ 10A 18M 1CY 1OC 23N 24P 2WC 31~ 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52P 52R 52S 52T 52X 53G 5GY 5RE 5VS 66C 6J9 6PF 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAFWJ AAONW AAWTL AAZKR ABCQN ABEML ACBNA ACCMX ACGFO ACPRK ACSCC ACXQS ADBBV ADIZJ ADPDF ADXAS AEGXH AEIMD AFBPY AFFNX AFZJQ AHMBA AI. AIAGR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ATUGU AZBYB BAFTC BAWUL BFHJK BKOMP BY8 C1A CS3 D-6 D-7 D-E D-F DCZOG DIK DR2 E3Z EBD EBS EIHBH EJD EMB EMOBN F00 F01 F04 F5P FAS FJW G-S GODZA GX1 H.X HZ~ IX1 J0M KQ8 L7B LC2 LC3 LH4 LW6 N04 N05 NF~ O66 O9- OHT OK1 OVD OVT P2P P2W P2X P2Z PQQKQ Q.N Q11 QB0 ROL RWL RX1 RXW SJN SUPJJ SV3 TAE TEORI TR2 TWZ UB1 UDS VH1 W2D W8V WH7 WHWMO WIN WOHZO WOQ WQJ WVDHM WXI XG1 XSB XV2 XZL YQJ ZCG ZGI ZVN ZXP ~WT 1OB AAYXX CITATION O8X CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ GUQSH H94 K9. M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U RC3 7X8
ID	FETCH-LOGICAL-c4599-8ae4a6e40b9977f759a2716ce4eeadd445696cf62c3b332365896ca113d94cb03
IEDL.DBID	7RV
ISICitedReferencesCount	671
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000306123900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0007-9235 1542-4863
IngestDate	Thu Sep 04 17:38:03 EDT 2025 Fri Oct 03 03:02:06 EDT 2025 Mon Jul 21 05:50:11 EDT 2025 Sat Nov 29 06:53:00 EST 2025 Tue Nov 18 22:12:49 EST 2025 Wed Aug 20 07:25:21 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor Published 2012 American Cancer Society, Inc.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4599-8ae4a6e40b9977f759a2716ce4eeadd445696cf62c3b332365896ca113d94cb03
Notes	We thank the following additional contributors to a companion publication to this article, “Cancer Treatment & Survivorship Facts & Figures 2012‐2013”: Rick Alteri, MD; Ronald Barr, MD; Keysha Brooks‐Coley, MA; Dana Chase, MD; John Daniel, MA; Stephen Edge, MD; Rachel Freedman, MD; James Gajewski, MD; Patricia Ganz, MD; Phillip Gray, MD; Natalie Hamm, RN, MSPH; Paul Jacobsen, PhD; Joan Kramer, MD; Alex Little, MD; Mark Litwin, MD; Ruth Rechis, PhD; Cheri Richards, MS; Lisa Richardson, MD; and Julia Rowland, PhD. This article is a US Government work and, as such, is in the public domain in the United States of America. doi: 10.3322/caac.21149. Available online at cacancerjournal.com The authors report no conflicts of interest. DISCLOSURES SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
OpenAccessLink	https://onlinelibrary.wiley.com/doi/pdfdirect/10.3322/caac.21149
PMID	22700443
PQID	1024540077
PQPubID	6515
PageCount	22
ParticipantIDs	proquest_miscellaneous_1024476631 proquest_journals_1024540077 pubmed_primary_22700443 crossref_primary_10_3322_caac_21149 crossref_citationtrail_10_3322_caac_21149 wiley_primary_10_3322_caac_21149_CAAC21149
PublicationCentury	2000
PublicationDate	July/August 2012
PublicationDateYYYYMMDD	2012-07-01
PublicationDate_xml	– month: 07 year: 2012 text: July/August 2012
PublicationDecade	2010
PublicationPlace	Hoboken
PublicationPlace_xml	– name: Hoboken – name: United States – name: Atlanta
PublicationTitle	CA: a cancer journal for clinicians
PublicationTitleAlternate	CA Cancer J Clin
PublicationYear	2012
Publisher	Wiley Subscription Services, Inc., A Wiley Company Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley Subscription Services, Inc
References	1995; 31 2004; 22 2005; 293 2011; 117 2007; 106 2010; 19 2002; 94 2002; 95 2004; 23 2002; 99 2002; 11 2006; 295 2003; 58 2004; 5 2010; 340 1997; 5 2004; 328 1997; 6 2007; 109 2009; 115 2011; 127 2004; 32 1998; 16 2004; 30 2000; 18 2000; 19 2009; 10 2010; 116 2010; 28 2005; 104 1993; 31 2002; 87 2008; 28 2008; 24 2009; 360 2008; 112 2010; 4 2011; 365 2010; 7 2012; 21 2007; 69 2009; 18 2010; 8 2007; 17 2007; 18 2001; 165 2005; 352 2006; 56 2005; 353 1983; 130 1981; 4 1998 1996 2003; 170 2003; 39 2011; 4 2003; 30 2007; 12 2003; 32 2012; 30 2007; 15 2006; 355 2007; 16 2011; 306 2003; 348 2010; 46 2002; 64 2003; 25 2003; 26 1985; 313 2005; 93 2003; 104 2006; 107 2012; 118 2003; 21 2012; 61 2001; 92 2010; 303 2000; 9 2000; 50 2002; 60 2011; 12 2008; 75 2005; 28 1998; 43 2003; 95 2005; 29 2003; 97 2003; 98 2005; 23 2003; 12 2010; 60 1991; 266 2001 1997; 11 2000; 55 2003; 8 2001; 19 2011; 20 2011; 22 2011; 21 2000; 163 2008; 66 2011; 28 2003; 82 2011; 29 2006; 243 2009; 59 2007; 26 2012; 62 2004; 101 2009; 23 2004; 100 2012 2011 2010 2006; 98 2006; 11 2007; 121 2006; 17 2008; 17 2006; 15 2008; 14 2009 2005; 41 2006 2010; 120 2005 1982; 127 2006; 4 1999; 6 2009; 27 2007; 57 2011; 103 1989; 321 2005; 165 2002; 20 2004; 19 2002; 23 2002; 21 2001; 9 2011; 41 2009; 7 2009; 5 2009; 302 (e_1_2_4_35_2) 2006 e_1_2_4_172_2 Ferrell BR (e_1_2_4_148_2) 1997; 11 Bleyer A (e_1_2_4_31_2) 2006 e_1_2_4_84_2 e_1_2_4_61_2 e_1_2_4_80_2 e_1_2_4_108_2 e_1_2_4_65_2 e_1_2_4_42_2 e_1_2_4_104_2 e_1_2_4_23_2 e_1_2_4_69_2 e_1_2_4_127_2 e_1_2_4_46_2 Steinherz LJ (e_1_2_4_72_2) 2001 e_1_2_4_88_2 American Cancer Society (e_1_2_4_32_2) 2012 e_1_2_4_27_2 e_1_2_4_123_2 e_1_2_4_169_2 e_1_2_4_188_2 e_1_2_4_165_2 Harpham WS (e_1_2_4_78_2) 1998 e_1_2_4_100_2 e_1_2_4_184_2 e_1_2_4_161_2 Surveillance, Epidemiology, and End Results (SEER)*Stat software (e_1_2_4_9_2) 2011 e_1_2_4_180_2 e_1_2_4_92_2 e_1_2_4_5_2 e_1_2_4_50_2 e_1_2_4_73_2 e_1_2_4_54_2 e_1_2_4_77_2 e_1_2_4_12_2 e_1_2_4_58_2 e_1_2_4_96_2 e_1_2_4_116_2 e_1_2_4_139_2 e_1_2_4_39_2 e_1_2_4_112_2 e_1_2_4_158_2 Freedman DM (e_1_2_4_44_2) 2006 e_1_2_4_135_2 e_1_2_4_177_2 e_1_2_4_154_2 e_1_2_4_171_2 e_1_2_4_81_2 Fashoyin‐Aje LA (e_1_2_4_144_2) Nieman CL (e_1_2_4_126_2) 2006; 4 e_1_2_4_20_2 e_1_2_4_43_2 e_1_2_4_66_2 e_1_2_4_89_2 e_1_2_4_24_2 Curtis RE (e_1_2_4_34_2) 2006 e_1_2_4_47_2 e_1_2_4_85_2 e_1_2_4_149_2 e_1_2_4_107_2 e_1_2_4_28_2 e_1_2_4_122_2 e_1_2_4_145_2 e_1_2_4_168_2 National Comprehensive Cancer Network (e_1_2_4_91_2) 2012 e_1_2_4_103_2 e_1_2_4_141_2 e_1_2_4_164_2 e_1_2_4_187_2 e_1_2_4_160_2 e_1_2_4_183_2 e_1_2_4_2_2 e_1_2_4_6_2 e_1_2_4_93_2 e_1_2_4_51_2 e_1_2_4_70_2 e_1_2_4_119_2 e_1_2_4_55_2 e_1_2_4_74_2 e_1_2_4_115_2 e_1_2_4_138_2 e_1_2_4_13_2 e_1_2_4_59_2 e_1_2_4_97_2 e_1_2_4_36_2 e_1_2_4_17_2 e_1_2_4_111_2 e_1_2_4_134_2 e_1_2_4_157_2 National Comprehensive Cancer Network (e_1_2_4_131_2) 2011 e_1_2_4_153_2 e_1_2_4_176_2 e_1_2_4_170_2 e_1_2_4_82_2 National Center for Health Statistics (e_1_2_4_175_2) 2009 e_1_2_4_40_2 e_1_2_4_21_2 e_1_2_4_63_2 e_1_2_4_48_2 e_1_2_4_86_2 e_1_2_4_106_2 e_1_2_4_25_2 e_1_2_4_67_2 e_1_2_4_129_2 World Health Organization (e_1_2_4_130_2) 1996 e_1_2_4_29_2 e_1_2_4_125_2 e_1_2_4_167_2 e_1_2_4_102_2 e_1_2_4_140_2 e_1_2_4_186_2 e_1_2_4_121_2 e_1_2_4_163_2 Howlader N (e_1_2_4_7_2) 2011 e_1_2_4_182_2 Morrison RS (e_1_2_4_142_2) 2011 e_1_2_4_3_2 Surveillance, Epidemiology, and End Results Program (e_1_2_4_16_2) 2010 e_1_2_4_94_2 e_1_2_4_71_2 e_1_2_4_90_2 Patrick DL (e_1_2_4_62_2) 2004; 32 e_1_2_4_33_2 e_1_2_4_52_2 e_1_2_4_75_2 e_1_2_4_137_2 e_1_2_4_14_2 e_1_2_4_37_2 e_1_2_4_56_2 e_1_2_4_79_2 e_1_2_4_98_2 e_1_2_4_118_2 e_1_2_4_133_2 e_1_2_4_179_2 e_1_2_4_18_2 e_1_2_4_114_2 e_1_2_4_156_2 e_1_2_4_110_2 Salz T (e_1_2_4_146_2) e_1_2_4_152_2 (e_1_2_4_10_2) 2011 e_1_2_4_150_2 e_1_2_4_83_2 e_1_2_4_60_2 e_1_2_4_109_2 e_1_2_4_22_2 e_1_2_4_41_2 e_1_2_4_64_2 e_1_2_4_105_2 e_1_2_4_26_2 e_1_2_4_45_2 e_1_2_4_68_2 e_1_2_4_87_2 e_1_2_4_128_2 e_1_2_4_49_2 e_1_2_4_124_2 e_1_2_4_147_2 e_1_2_4_166_2 e_1_2_4_189_2 e_1_2_4_101_2 e_1_2_4_120_2 e_1_2_4_143_2 e_1_2_4_162_2 e_1_2_4_185_2 e_1_2_4_181_2 e_1_2_4_4_2 e_1_2_4_8_2 e_1_2_4_95_2 Barrera S (e_1_2_4_173_2) 2009; 23 e_1_2_4_30_2 e_1_2_4_76_2 e_1_2_4_11_2 e_1_2_4_53_2 e_1_2_4_117_2 e_1_2_4_159_2 e_1_2_4_15_2 e_1_2_4_57_2 e_1_2_4_99_2 e_1_2_4_38_2 e_1_2_4_19_2 e_1_2_4_113_2 e_1_2_4_136_2 e_1_2_4_155_2 e_1_2_4_178_2 e_1_2_4_132_2 e_1_2_4_151_2 e_1_2_4_174_2 CA Cancer J Clin. 2012 Sep-Oct;62(5):348
References_xml	– year: 2011 – volume: 116 start-page: 1171 year: 2010 end-page: 1183 article-title: Reproductive outcomes for survivors of childhood cancer publication-title: Obstet Gynecol. – volume: 30 start-page: 79 year: 2004 end-page: 93 article-title: Sexuality and health‐related quality of life after prostate cancer in African‐American and white men treated for localized disease publication-title: J Sex Marital Ther. – volume: 21 start-page: 1660 year: 2003 end-page: 1668 article-title: Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes publication-title: J Clin Oncol. – volume: 15 start-page: 1086 year: 2006 end-page: 1092 article-title: Gender differences in caregiving stress among caregivers of cancer survivors publication-title: Psychooncology. – volume: 25 start-page: 16 year: 2003 end-page: 24 article-title: The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence publication-title: Ann Behav Med. – volume: 23 start-page: 15 issue: 2 suppl Nurse Ed year: 2009 end-page: 21 article-title: Nutrition during and after cancer therapy publication-title: Oncology (Williston Park). – volume: 348 start-page: 1625 year: 2003 end-page: 1638 article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults publication-title: N Engl J Med. – volume: 12 start-page: 52 issue: suppl 1 year: 2007 end-page: 67 article-title: Integrative nonpharmacologic behavioral interventions for the management of cancer‐related fatigue publication-title: Oncologist. – volume: 321 start-page: 136 year: 1989 end-page: 142 article-title: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia publication-title: N Engl J Med. – volume: 32 start-page: 9 year: 2004 end-page: 16 article-title: National Institutes of Health State‐of‐the‐Science Panel. National Institutes of Health State‐of‐the‐Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15‐17, 2002 publication-title: J Natl Cancer Inst Monogr. – volume: 23 start-page: 6613 year: 2005 end-page: 6622 article-title: Use of a case definition approach to identify cancer‐related fatigue in women undergoing adjuvant therapy for breast cancer publication-title: J Clin Oncol. – volume: 120 start-page: 2446 year: 2010 end-page: 2451 article-title: The increasing incidence of small thyroid cancers: where are the cases coming from? publication-title: Laryngoscope. – volume: 95 start-page: 1165 year: 2003 end-page: 1168 article-title: T‐cell homeostasis in breast cancer survivors with persistent fatigue publication-title: J Natl Cancer Inst. – volume: 106 start-page: 85 year: 2007 end-page: 95 article-title: Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors publication-title: Breast Cancer Res Treat. – volume: 98 start-page: 1786 year: 2003 end-page: 1801 article-title: Cancer‐related fatigue: evolving concepts in evaluation and treatment publication-title: Cancer. – volume: 303 start-page: 1054 year: 2010 end-page: 1061 article-title: Availability and integration of palliative care at US cancer centers publication-title: JAMA. – volume: 58 start-page: 82 year: 2003 end-page: 91 article-title: Cancer survivors in the United States: age, health, and disability publication-title: J Gerontol A Biol Sci Med Sci. – volume: 16 start-page: 214 year: 2007 end-page: 223 article-title: A family‐based model to predict fear of recurrence for cancer survivors and their caregivers publication-title: Psychooncology. – volume: 20 start-page: 123 year: 2011 end-page: 133 article-title: Efficacy of exercise interventions in modulating cancer‐related fatigue among adult cancer survivors: a meta‐analysis publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 23 start-page: 595 year: 2004 end-page: 598 article-title: Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis publication-title: Health Psychol. – volume: 31 start-page: 1205 year: 1995 end-page: 1211 article-title: Radiation injury to the heart publication-title: Int J Radiat Oncol Biol Phys. – volume: 27 start-page: 4980 year: 2009 end-page: 4985 article-title: Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort publication-title: J Clin Oncol. – volume: 352 start-page: 154 year: 2005 end-page: 164 article-title: Risk of fracture after androgen deprivation for prostate cancer publication-title: N Engl J Med. – volume: 94 start-page: 39 year: 2002 end-page: 49 article-title: Quality of life in long‐term, disease‐free survivors of breast cancer: a follow‐up study publication-title: J Natl Cancer Inst. – volume: 8 start-page: 46 year: 2003 end-page: 56 article-title: Family caregivers and indicators of cancer–related distress publication-title: Psychol Health Med. – volume: 23 start-page: 7428 year: 2005 end-page: 7436 article-title: Quality of life and sexual functioning in cervical cancer survivors publication-title: J Clin Oncol. – volume: 62 start-page: 30 year: 2012 end-page: 67 article-title: American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity publication-title: CA Cancer J Clin. – volume: 22 start-page: 322 year: 2004 end-page: 329 article-title: Clinical cardiac tolerability of trastuzumab publication-title: J Clin Oncol. – volume: 16 start-page: S166 issue: suppl 2 year: 2007 end-page: S168 article-title: Cognitive side‐effects of adjuvant treatments publication-title: Breast. – volume: 21 start-page: 4175 year: 2003 end-page: 4183 article-title: Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer publication-title: J Clin Oncol. – volume: 16 start-page: 501 year: 1998 end-page: 514 article-title: Life after breast cancer: understanding women's health‐related quality of life and sexual functioning publication-title: J Clin Oncol. – volume: 116 start-page: 5767 year: 2010 end-page: 5776 article-title: Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients publication-title: Cancer. – volume: 355 start-page: 1572 year: 2006 end-page: 1582 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N Engl J Med. – volume: 6 start-page: 256 year: 1999 end-page: 263 article-title: Is fatigue a long‐term side effect of breast cancer treatment? publication-title: Cancer Control. – volume: 97 start-page: 789 issue: suppl 3 year: 2003 end-page: 795 article-title: Diagnosis and management of treatment‐related osteoporosis in men with prostate carcinoma publication-title: Cancer. – volume: 5 start-page: 44 year: 1997 end-page: 52 article-title: Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer publication-title: Support Care Cancer. – volume: 28 start-page: 4074 year: 2010 end-page: 4080 article-title: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers publication-title: J Clin Oncol. – volume: 17 start-page: 435 year: 2008 end-page: 446 article-title: Psychosocial outcomes and health‐related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 11 start-page: 132 year: 2002 end-page: 141 article-title: Quality of life in childhood cancer survivors publication-title: Psychooncology. – volume: 31 start-page: 732 year: 1993 end-page: 748 article-title: Potential for cancer related health services research using a linked Medicare‐tumor registry database publication-title: Med Care. – volume: 29 start-page: 2750 year: 2011 end-page: 2752 article-title: Palliative care and the quality of life publication-title: J Clin Oncol. – volume: 117 start-page: 1994 year: 2011 end-page: 2003 article-title: Cancer‐related chronic pain: examining quality of life in diverse cancer survivors publication-title: Cancer. – volume: 18 start-page: 784 year: 2009 end-page: 791 article-title: Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980‐2005 publication-title: Cancer Epidemiol Biomarkers Prev. – start-page: 523 year: 2005 end-page: 527 article-title: Sexuality and fertility after cancer publication-title: Hematology Am Soc Hematol Educ Program. – volume: 41 start-page: 761 year: 2011 end-page: 767 article-title: Psychostimulants for the management of cancer‐related fatigue: a systematic review and meta‐analysis publication-title: J Pain Symptom Manage. – volume: 109 start-page: 1715 year: 2007 end-page: 1720 article-title: Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction publication-title: Cancer. – volume: 295 start-page: 387 year: 2006 end-page: 388 article-title: Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act publication-title: JAMA. – volume: 9 start-page: 11 year: 2001 end-page: 17 article-title: Fatigue in disease‐free cancer patients compared with fatigue in patients with chronic fatigue syndrome publication-title: Support Care Cancer. – volume: 5 start-page: 6 year: 2009 end-page: 9 article-title: Smoking behaviors among cancer survivors: an observational clinical study publication-title: J Oncol Pract. – volume: 20 start-page: 44 year: 2011 end-page: 52 article-title: Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue? publication-title: Psychooncology. – volume: 18 start-page: 1570 year: 2000 end-page: 1593 article-title: Osteoporosis due to cancer treatment: pathogenesis and management publication-title: J Clin Oncol. – volume: 87 start-page: 3656 year: 2002 end-page: 3661 article-title: Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs publication-title: J Clin Endocrinol Metab. – volume: 43 start-page: 627 year: 1998 end-page: 633 article-title: Neurological and neuroradiological findings in long‐term survivors of allogeneic bone marrow transplantation publication-title: Ann Neurol. – start-page: 2904 year: 2001 end-page: 2931 – volume: 59 start-page: 8 year: 2009 end-page: 24 article-title: Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment publication-title: CA Cancer J Clin. – volume: 19 start-page: 2437 year: 2010 end-page: 2444 article-title: Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004‐2006 publication-title: Cancer Epidemiol Biomarkers Prev. – year: 2010 – volume: 17 start-page: 184 year: 2007 end-page: 189 article-title: Nodular lymphocyte‐predominant hodgkin lymphoma publication-title: Semin Radiat Oncol. – volume: 5 start-page: 270 year: 2004 end-page: 271 article-title: Do systemic cancer treatments affect cognitive function? publication-title: Lancet Oncol. – volume: 28 start-page: 1308 year: 2010 end-page: 1315 article-title: Role of cancer treatment in long‐term overall and cardiovascular mortality after childhood cancer publication-title: J Clin Oncol. – volume: 30 start-page: 799 year: 2003 end-page: 813 article-title: Psychosocial and sexual functioning of survivors of breast cancer publication-title: Semin Oncol. – volume: 24 start-page: 171 year: 2008 end-page: 179 article-title: Nutrition and the cancer survivor: evidence to guide oncology nursing practice publication-title: Semin Oncol Nurs. – volume: 28 start-page: 289 year: 2005 end-page: 294 article-title: Randomized trials of breast‐conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results publication-title: Am J Clin Oncol. – volume: 109 start-page: 1756 year: 2007 end-page: 1762 article-title: Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) publication-title: Cancer. – volume: 92 start-page: 1368 year: 2001 end-page: 1377 article-title: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis publication-title: Cancer. – volume: 29 start-page: 236 year: 2005 end-page: 245 article-title: Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long‐term breast cancer survivors publication-title: Ann Behav Med. – volume: 66 start-page: 218 year: 2008 end-page: 228 article-title: Peripheral nerve damage associated with administration of taxanes in patients with cancer publication-title: Crit Rev Oncol Hematol. – volume: 4 start-page: 502 year: 2011 end-page: 511 article-title: Colorectal cancer survivorship: movement matters publication-title: Cancer Prev Res (Phila). – volume: 39 start-page: 2179 year: 2003 end-page: 2186 article-title: Fatigue in long‐term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG) publication-title: Eur J Cancer. – volume: 360 start-page: 902 year: 2009 end-page: 911 article-title: Preservation of fertility in patients with cancer publication-title: N Engl J Med. – volume: 243 start-page: 241 year: 2006 end-page: 249 article-title: A multi‐institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network publication-title: Ann Surg. – volume: 302 start-page: 1202 year: 2009 end-page: 1209 article-title: Outcomes of localized prostate cancer following conservative management publication-title: JAMA. – volume: 20 start-page: 485 year: 2002 end-page: 493 article-title: Neuropsychologic impact of standard‐dose systemic chemotherapy in long‐term survivors of breast cancer and lymphoma publication-title: J Clin Oncol. – volume: 95 start-page: 2431 year: 2002 end-page: 2441 article-title: Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study publication-title: Cancer. – volume: 28 start-page: 4135 year: 2010 end-page: 4141 article-title: Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004‐2006 publication-title: J Clin Oncol. – volume: 127 start-page: 250 year: 1982 end-page: 252 article-title: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases publication-title: J Urol. – volume: 9 start-page: 232 year: 2000 end-page: 242 article-title: Couples dealing with cancer: role and gender differences regarding psychological distress and quality of life publication-title: Psychooncology. – volume: 8 start-page: 904 year: 2010 end-page: 931 article-title: Cancer‐related fatigue publication-title: J Natl Compr Canc Netw. – volume: 101 start-page: 2837 year: 2004 end-page: 2842 article-title: Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignancies publication-title: Cancer. – volume: 18 start-page: 337 year: 2009 end-page: 342 article-title: Physical activity in cancer survivors: a field in motion publication-title: Psychooncology. – volume: 98 start-page: 521 year: 2006 end-page: 529 article-title: Functional limitations in elderly female cancer survivors publication-title: J Natl Cancer Inst. – volume: 163 start-page: 181 year: 2000 end-page: 186 article-title: Progressive osteoporosis during androgen deprivation therapy for prostate cancer publication-title: J Urol. – volume: 55 start-page: 153 year: 2000 end-page: 162 article-title: Long‐term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model publication-title: Radiother Oncol. – volume: 12 start-page: 160 year: 2011 end-page: 174 article-title: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative‐care settings: a meta‐analysis of 94 interview‐based studies publication-title: Lancet Oncol. – volume: 118 start-page: 1100 year: 2012 end-page: 1109 article-title: Predicting US‐ and state‐level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence publication-title: Cancer. – volume: 306 start-page: 721 year: 2011 end-page: 728 article-title: Use of radioactive iodine for thyroid cancer publication-title: JAMA. – volume: 340 start-page: b5569 year: 2010 article-title: Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta‐analysis publication-title: BMJ. – year: 2009 – volume: 23 start-page: 406 year: 2002 end-page: 416 article-title: Preliminary evaluation of a clinical syndrome approach to assessing cancer‐related fatigue publication-title: J Pain Symptom Manage. – volume: 104 start-page: 2565 issue: suppl 11 year: 2005 end-page: 2576 article-title: Adult cancer survivors: how are they faring? publication-title: Cancer. – volume: 127 start-page: 18 year: 2011 end-page: 26 article-title: Are patients making high‐quality decisions about breast reconstruction after mastectomy? [outcomes article] publication-title: Plast Reconstr Surg. – volume: 26 start-page: 604 year: 2003 end-page: 614 article-title: Multidimensional independent predictors of cancer‐related fatigue publication-title: J Pain Symptom Manage. – volume: 21 start-page: 125 year: 2011 end-page: 134 article-title: Thyroid cancer incidence patterns in the United States by histologic type, 1992‐2006 publication-title: Thyroid. – volume: 22 start-page: 2233 year: 2004 end-page: 2239 article-title: Cognitive impairment associated with chemotherapy for cancer: report of a workshop publication-title: J Clin Oncol. – volume: 56 start-page: 254 year: 2006 end-page: 281 article-title: American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity publication-title: CA Cancer J Clin. – volume: 6 start-page: 95 year: 1997 end-page: 105 article-title: Fear of cancer recurrence–a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears publication-title: Psychooncology. – volume: 64 start-page: 604 year: 2002 end-page: 611 article-title: Fatigue and proinflammatory cytokine activity in breast cancer survivors publication-title: Psychosom Med. – volume: 21 start-page: 517 year: 2012 end-page: 525 article-title: Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers publication-title: Qual Life Res. – volume: 107 start-page: 1551 year: 2006 end-page: 1561 article-title: Treatment outcome in young adults and children > 10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol publication-title: Cancer. – volume: 21 start-page: 774 year: 2003 end-page: 780 article-title: Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE‐93 and LALA‐94 trials publication-title: J Clin Oncol. – volume: 30 start-page: 229 year: 2012 end-page: 231 article-title: “Doctor, will the treatment you are recommending cause chemobrain?” publication-title: J Clin Oncol. – volume: 115 start-page: 4362 issue: suppl 18 year: 2009 end-page: 4373 article-title: Time costs associated with informal caregiving for cancer survivors publication-title: Cancer. – article-title: New patient‐centered care standards from the Commission on Cancer: opportunities and challenges [published online ahead of print March 20, 2012] publication-title: J Support Oncol. – volume: 97 start-page: 1564 year: 2003 end-page: 1572 article-title: Fatigue in ovarian carcinoma patients: a neglected issue? publication-title: Cancer. – volume: 21 start-page: 1249 year: 2003 end-page: 1254 article-title: Fatigue, anxiety, and depression in long‐term survivors of testicular cancer publication-title: J Clin Oncol. – volume: 11 start-page: 96 year: 2006 end-page: 110 article-title: The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors publication-title: Oncologist. – volume: 82 start-page: 23 year: 2003 end-page: 28 article-title: Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin) publication-title: Breast Cancer Res Treat. – article-title: Survivorship care plans in research and practice [published online ahead of print January 12, 2012] publication-title: CA Cancer J Clin. – volume: 121 start-page: 2233 year: 2007 end-page: 2240 article-title: New malignancies following childhood cancer in the United States, 1973‐2002 publication-title: Int J Cancer. – volume: 28 start-page: 1511 year: 2008 end-page: 1522 article-title: Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer publication-title: Pharmacotherapy. – volume: 266 start-page: 1672 year: 1991 end-page: 1677 article-title: Cardiac toxicity 4 to 20 years after completing anthracycline therapy publication-title: JAMA. – volume: 21 start-page: 3511 year: 2002 end-page: 3526 article-title: Estimation and projections of cancer prevalence from cancer registry data publication-title: Stat Med. – volume: 104 start-page: 488 year: 2003 end-page: 495 article-title: Health profiles in 5836 long‐term cancer survivors publication-title: Int J Cancer. – volume: 20 start-page: 2015 year: 2011 end-page: 2021 article-title: Support for caregivers of cancer patients: transition after active treatment publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 99 start-page: 8886 year: 2002 end-page: 8891 article-title: Transformation of follicular lymphoma to diffuse large‐cell lymphoma: alternative patterns with increased or decreased expression of c‐myc and its regulated genes publication-title: Proc Natl Acad Sci U S A. – volume: 60 start-page: 317 year: 2010 end-page: 339 article-title: Interventions with family caregivers of cancer patients: meta‐analysis of randomized trials publication-title: CA Cancer J Clin. – volume: 16 start-page: 1689 year: 1998 end-page: 1696 article-title: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer publication-title: J Clin Oncol. – volume: 115 start-page: 2999 year: 2009 end-page: 3008 article-title: Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node‐positive, operable breast cancer publication-title: Cancer. – volume: 57 start-page: 242 year: 2007 end-page: 255 article-title: Young adult oncology: the patients and their survival challenges publication-title: CA Cancer J Clin. – volume: 19 start-page: 812 year: 2001 end-page: 820 article-title: Cognitive effects of standard‐dose chemotherapy in patients with cancer publication-title: Cancer Invest. – volume: 41 start-page: 2613 year: 2005 end-page: 2619 article-title: Quality of life among long‐term breast cancer survivors: a systematic review publication-title: Eur J Cancer. – volume: 15 start-page: 621 year: 2007 end-page: 630 article-title: The impact of a cancer diagnosis on the health behaviors of cancer survivors and their family and friends publication-title: Support Care Cancer. – volume: 28 start-page: 867 year: 2011 end-page: 883 article-title: Optimal management of cancer treatment‐induced bone loss: considerations for elderly patients publication-title: Drugs Aging. – volume: 32 start-page: 486 year: 2003 end-page: 491 article-title: Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients publication-title: Int J Oral Maxillofac Surg. – volume: 93 start-page: 200 year: 2005 end-page: 207 article-title: Fertility, gonadal and sexual function in survivors of testicular cancer publication-title: Br J Cancer. – volume: 4 start-page: 171 year: 2006 end-page: 178 article-title: Cancer survivors and infertility: a review of a new problem and novel answers publication-title: J Support Oncol. – volume: 30 start-page: 49 issue: 5 suppl 16 year: 2003 end-page: 53 article-title: Trastuzumab and cardiac dysfunction: update on preclinical studies publication-title: Semin Oncol. – volume: 28 start-page: 4052 year: 2010 end-page: 4057 article-title: Time course of risk factors in cancer etiology and progression publication-title: J Clin Oncol. – volume: 7 start-page: S1 issue: suppl 3 year: 2009 end-page: S32 article-title: NCCN Task Force Report: Bone Health in Cancer Care publication-title: J Natl Compr Canc Netw. – volume: 59 start-page: 391 year: 2009 end-page: 410 article-title: Adult cancer survivorship: evolution, research, and planning care publication-title: CA Cancer J Clin. – volume: 69 start-page: 283 year: 2007 end-page: 291 article-title: Benefit‐finding in the cancer caregiving experience publication-title: Psychosom Med. – volume: 12 start-page: 4 issue: suppl 1 year: 2007 end-page: 10 article-title: Cancer‐related fatigue: the scale of the problem publication-title: Oncologist. – volume: 313 start-page: 270 year: 1985 end-page: 273 article-title: Seasons of survival: reflections of a physician with cancer publication-title: N Engl J Med. – volume: 10 start-page: 957 year: 2009 end-page: 966 article-title: Dexamethasone‐based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL‐9 (1997‐2004) publication-title: Lancet Oncol. – volume: 165 start-page: 552 year: 2005 end-page: 558 article-title: Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study publication-title: Arch Intern Med. – volume: 19 start-page: 1 year: 2004 end-page: 13 article-title: Association between current lifestyle behaviors and health‐related quality of life in breast, colorectal, and prostate cancer survivors publication-title: Psychol Health. – volume: 60 start-page: 79 issue: 3 suppl 1 year: 2002 end-page: 85 article-title: Osteoporosis during androgen deprivation therapy for prostate cancer publication-title: Urology. – volume: 18 start-page: 1437 year: 2007 end-page: 1449 article-title: Prevalence of pain in patients with cancer: a systematic review of the past 40 years publication-title: Ann Oncol. – volume: 295 start-page: 2164 year: 2006 end-page: 2167 article-title: Increasing incidence of thyroid cancer in the United States, 1973‐2002 publication-title: JAMA. – volume: 7 start-page: 564 year: 2010 end-page: 575 article-title: Cardiotoxicity of anticancer treatments: what the cardiologist needs to know publication-title: Nat Rev Cardiol. – volume: 100 start-page: 2292 year: 2004 end-page: 2299 article-title: The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial publication-title: Cancer. – volume: 27 start-page: 4177 year: 2009 end-page: 4181 article-title: Comparison of commission on cancer‐approved and ‐nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base publication-title: J Clin Oncol. – start-page: 889 year: 1998 end-page: 907 – volume: 94 start-page: 528 year: 2002 end-page: 538 article-title: Fatigue in cancer patients compared with fatigue in the general United States population publication-title: Cancer. – volume: 20 start-page: 3461 year: 2002 end-page: 3469 article-title: Tobacco use outcomes among patients with lung cancer treated for nicotine dependence publication-title: J Clin Oncol. – year: 1996 – volume: 165 start-page: 430 year: 2001 end-page: 435 article-title: The development of erectile dysfunction in men treated for prostate cancer publication-title: J Urol. – volume: 170 start-page: 1931 year: 2003 end-page: 1933 article-title: Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE publication-title: J Urol. – volume: 19 start-page: 446 year: 2000 end-page: 456 article-title: High level of fatigue in lymphoma patients treated with high dose therapy publication-title: J Pain Symptom Manage. – volume: 103 start-page: 1214 year: 2011 end-page: 1215 article-title: Assessing survivorship care plans publication-title: J Natl Cancer Inst. – volume: 353 start-page: 1784 year: 2005 end-page: 1792 article-title: Effect of screening and adjuvant therapy on mortality from breast cancer publication-title: N Engl J Med. – volume: 103 start-page: 117 year: 2011 end-page: 128 article-title: Projections of the cost of cancer care in the United States: 2010‐2020 publication-title: J Natl Cancer Inst. – volume: 16 start-page: 413 year: 2007 end-page: 428 article-title: Examining predictive models of HRQOL in a population‐based, multiethnic sample of women with breast carcinoma publication-title: Qual Life Res. – volume: 26 start-page: 660 year: 2007 end-page: 667 article-title: Systematic review and meta‐analysis of psychological and activity‐based interventions for cancer‐related fatigue publication-title: Health Psychol. – volume: 22 start-page: 811 year: 2011 end-page: 826 article-title: Physical activity and cancer prevention: a systematic review of clinical trials publication-title: Cancer Causes Control. – volume: 365 start-page: 395 year: 2011 end-page: 409 article-title: Reduced lung‐cancer mortality with low‐dose computed tomographic screening publication-title: N Engl J Med. – year: 2012 – volume: 23 start-page: 5458 year: 2005 end-page: 5460 article-title: A teachable moment for oncologists: cancer survivors, 10 million strong and growing! publication-title: J Clin Oncol. – volume: 17 start-page: 1215 year: 2006 end-page: 1226 article-title: Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000‐2020 publication-title: Cancer Causes Control. – volume: 293 start-page: 2095 year: 2005 end-page: 2101 article-title: 20‐year outcomes following conservative management of clinically localized prostate cancer publication-title: JAMA. – volume: 50 start-page: 271 year: 2000 end-page: 284 article-title: Couples' patterns of adjustment to colon cancer publication-title: Soc Sci Med. – volume: 75 start-page: 531 year: 2008 end-page: 539 article-title: Children's Oncology Group. Monitoring pulmonary complications in long‐term childhood cancer survivors: guidelines for the primary care physician publication-title: Cleve Clin J Med. – volume: 107 start-page: 729 year: 2006 end-page: 737 article-title: Variations in reconstruction after radical cystectomy publication-title: Cancer. – volume: 46 start-page: 2879 year: 2010 end-page: 2888 article-title: Quality of life among long‐term (≥ 5 years) colorectal cancer survivors–systematic review publication-title: Eur J Cancer. – volume: 4 start-page: 213 year: 1981 end-page: 220 article-title: Mastectomy patients and the fear of cancer recurrence publication-title: Cancer Nurs. – volume: 101 start-page: 1514 year: 2004 end-page: 1523 article-title: The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer publication-title: Cancer. – year: 2006 – volume: 130 start-page: 1083 year: 1983 end-page: 1086 article-title: Superficial bladder cancer: progression and recurrence publication-title: J Urol. – volume: 360 start-page: 2730 year: 2009 end-page: 2741 article-title: Treating childhood acute lymphoblastic leukemia without cranial irradiation publication-title: N Engl J Med. – volume: 12 start-page: 463 year: 2003 end-page: 473 article-title: Finding help for sexual problems after prostate cancer treatment: a phone survey of men's and women's perspectives publication-title: Psychooncology. – volume: 112 start-page: 5 year: 2008 end-page: 13 article-title: How common is fatigue in disease‐free breast cancer survivors? A systematic review of the literature publication-title: Breast Cancer Res Treat. – volume: 11 start-page: 565 year: 1997 end-page: 568 article-title: Quality of life among long‐term cancer survivors publication-title: Oncology (Williston Park). – volume: 328 start-page: 1470 year: 2004 end-page: 1476 article-title: Stigma, shame, and blame experienced by patients with lung cancer: qualitative study publication-title: BMJ. – start-page: 339 year: 2006 end-page: 362 – volume: 92 start-page: 1689 issue: suppl 6 year: 2001 end-page: 1693 article-title: Effects of exercise on cancer‐related fatigue publication-title: Cancer. – start-page: 841 year: 2006 end-page: 871 – volume: 14 start-page: 435 year: 2008 end-page: 441 article-title: Impact of nutrition and exercise on cancer survival publication-title: Cancer J. – volume: 61 start-page: 705 year: 2012 end-page: 711 article-title: Long‐term outcomes of selective bladder preservation by combined‐modality therapy for invasive bladder cancer: the MGH experience publication-title: Eur Urol. – volume: 4 start-page: 353 year: 2010 end-page: 360 article-title: Incidence of testicular cancer in the United States, 1999‐2004 publication-title: Am J Mens Health. – ident: e_1_2_4_33_2 doi: 10.1016/j.ejca.2010.06.010 – ident: e_1_2_4_18_2 doi: 10.1002/cncr.22598 – ident: e_1_2_4_51_2 doi: 10.1001/jama.295.18.2164 – ident: e_1_2_4_152_2 doi: 10.1158/1055-9965.EPI-07-2541 – ident: e_1_2_4_5_2 doi: 10.1093/jnci/djq495 – ident: e_1_2_4_185_2 doi: 10.1002/1099-1611(200005/06)9:3<232::AID-PON458>3.0.CO;2-J – volume-title: NCCN Clinical Practice Guidelines in Oncology. Distress Management. Version 1.2012 year: 2012 ident: e_1_2_4_91_2 – ident: e_1_2_4_112_2 doi: 10.1158/1055-9965.EPI-10-0988 – ident: e_1_2_4_172_2 doi: 10.3322/canjclin.56.5.254 – ident: e_1_2_4_163_2 doi: 10.1136/bmj.b5569 – ident: e_1_2_4_179_2 doi: 10.3322/caac.20081 – ident: e_1_2_4_166_2 doi: 10.1634/theoncologist.12-S1-52 – ident: e_1_2_4_104_2 doi: 10.1200/JCO.2005.07.024 – ident: e_1_2_4_111_2 doi: 10.1007/BF01681961 – ident: e_1_2_4_146_2 article-title: Survivorship care plans in research and practice [published online ahead of print January 12, 2012] publication-title: CA Cancer J Clin. – ident: e_1_2_4_79_2 doi: 10.1016/0360-3016(94)00656-6 – ident: e_1_2_4_151_2 doi: 10.1016/j.ejca.2005.05.017 – ident: e_1_2_4_61_2 doi: 10.1002/cncr.25681 – ident: e_1_2_4_140_2 doi: 10.1182/asheducation-2005.1.523 – ident: e_1_2_4_36_2 doi: 10.1093/acprof:oso/9780195149616.003.0044 – ident: e_1_2_4_113_2 doi: 10.1037/0278-6133.26.6.660 – ident: e_1_2_4_86_2 doi: 10.1200/JCO.2004.08.094 – ident: e_1_2_4_13_2 doi: 10.1002/cncr.24363 – ident: e_1_2_4_47_2 doi: 10.1200/JCO.2008.21.2613 – ident: e_1_2_4_102_2 doi: 10.1016/S0885-3924(00)00144-5 – volume-title: SEER Cancer Statistics Review, 1975‐2008 year: 2011 ident: e_1_2_4_7_2 – ident: e_1_2_4_69_2 doi: 10.1002/cncr.11149 – ident: e_1_2_4_60_2 doi: 10.1002/cncr.22556 – ident: e_1_2_4_67_2 doi: 10.1210/jcem.87.8.8782 – ident: e_1_2_4_28_2 doi: 10.1200/JCO.2003.02.053 – ident: e_1_2_4_75_2 doi: 10.1053/j.seminoncol.2003.08.007 – ident: e_1_2_4_52_2 doi: 10.1089/thy.2010.0021 – ident: e_1_2_4_116_2 doi: 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B – ident: e_1_2_4_135_2 doi: 10.1002/pon.657 – ident: e_1_2_4_139_2 doi: 10.1097/00005392-200102000-00019 – ident: e_1_2_4_94_2 doi: 10.6004/jnccn.2010.0067 – volume: 4 start-page: 171 year: 2006 ident: e_1_2_4_126_2 article-title: Cancer survivors and infertility: a review of a new problem and novel answers publication-title: J Support Oncol. – ident: e_1_2_4_45_2 doi: 10.1001/jama.293.17.2095 – ident: e_1_2_4_53_2 doi: 10.1001/archinte.165.5.552 – volume-title: America's Care of Serious Illness: A State‐by‐State Report Card on Access to Palliative Care in Our Nation's Hospitals year: 2011 ident: e_1_2_4_142_2 – ident: e_1_2_4_136_2 doi: 10.1200/JCO.2004.00.3996 – ident: e_1_2_4_20_2 doi: 10.1097/01.sla.0000197738.63512.23 – ident: e_1_2_4_100_2 doi: 10.1097/00006842-200207000-00010 – ident: e_1_2_4_105_2 doi: 10.1016/S0885-3924(02)00388-3 – ident: e_1_2_4_137_2 doi: 10.1200/JCO.1998.16.2.501 – ident: e_1_2_4_73_2 doi: 10.1001/jama.1991.03470120074036 – ident: e_1_2_4_115_2 doi: 10.1016/S0901-5027(03)90399-1 – ident: e_1_2_4_11_2 doi: 10.1200/JCO.2008.21.7018 – ident: e_1_2_4_39_2 doi: 10.1056/NEJM198907203210302 – ident: e_1_2_4_108_2 doi: 10.1177/107327489900600304 – ident: e_1_2_4_188_2 doi: 10.1097/PSY.0b013e3180417cf4 – ident: e_1_2_4_165_2 doi: 10.1200/JCO.2003.04.093 – ident: e_1_2_4_43_2 doi: 10.1136/bmj.38111.639734.7C – ident: e_1_2_4_119_2 doi: 10.1207/S15324796ABM2501_03 – ident: e_1_2_4_68_2 doi: 10.1016/S0090-4295(02)01579-0 – start-page: 2904 volume-title: Cancer: Principles and Practice of Oncology year: 2001 ident: e_1_2_4_72_2 – ident: e_1_2_4_170_2 doi: 10.1158/1940-6207.CAPR-11-0098 – ident: e_1_2_4_158_2 doi: 10.1056/NEJMoa021423 – ident: e_1_2_4_161_2 doi: 10.1007/s10552-011-9761-4 – ident: e_1_2_4_48_2 doi: 10.1592/phco.28.12.1511 – ident: e_1_2_4_114_2 doi: 10.1016/j.jpainsymman.2010.06.020 – ident: e_1_2_4_122_2 doi: 10.1056/NEJMra0801454 – ident: e_1_2_4_83_2 doi: 10.1016/S1470-2045(04)01463-9 – ident: e_1_2_4_57_2 doi: 10.1016/S0022-5347(17)51695-X – ident: e_1_2_4_12_2 doi: 10.1158/1055-9965.EPI-10-0299 – ident: e_1_2_4_171_2 doi: 10.1016/j.soncn.2008.05.005 – ident: e_1_2_4_19_2 doi: 10.1001/jama.295.4.387 – ident: e_1_2_4_117_2 doi: 10.1097/01.ju.0000091993.73842.9b – ident: e_1_2_4_156_2 doi: 10.1002/pon.569 – ident: e_1_2_4_70_2 doi: 10.1056/NEJMoa041943 – ident: e_1_2_4_95_2 doi: 10.1002/cncr.10245 – ident: e_1_2_4_97_2 doi: 10.1002/cncr.11742 – ident: e_1_2_4_4_2 doi: 10.1007/s10552-006-0072-0 – ident: e_1_2_4_180_2 doi: 10.1200/JCO.2005.04.916 – ident: e_1_2_4_23_2 doi: 10.1056/NEJMoa050518 – ident: e_1_2_4_164_2 doi: 10.1080/08870440310001606507 – volume: 11 start-page: 565 year: 1997 ident: e_1_2_4_148_2 article-title: Quality of life among long‐term cancer survivors publication-title: Oncology (Williston Park). – ident: e_1_2_4_85_2 doi: 10.1002/ijc.10981 – ident: e_1_2_4_46_2 doi: 10.1001/jama.2009.1348 – ident: e_1_2_4_154_2 doi: 10.1093/gerona/58.1.M82 – ident: e_1_2_4_38_2 doi: 10.1016/S1470-2045(09)70228-1 – ident: e_1_2_4_87_2 doi: 10.1200/JCO.2003.01.119 – ident: e_1_2_4_133_2 doi: 10.1002/cncr.10978 – ident: e_1_2_4_149_2 doi: 10.1093/jnci/94.1.39 – ident: e_1_2_4_150_2 doi: 10.1007/s11136-006-9138-4 – ident: e_1_2_4_22_2 doi: 10.1002/cncr.20529 – volume-title: Cancer Prevention & Early Detection Facts & Figures 2012 year: 2012 ident: e_1_2_4_32_2 – ident: e_1_2_4_153_2 doi: 10.1007/s10549-006-9479-2 – volume: 23 start-page: 15 issue: 2 year: 2009 ident: e_1_2_4_173_2 article-title: Nutrition during and after cancer therapy publication-title: Oncology (Williston Park). – ident: e_1_2_4_54_2 doi: 10.1158/1055-9965.EPI-08-0960 – ident: e_1_2_4_82_2 doi: 10.1200/JCO.2002.20.2.485 – ident: e_1_2_4_50_2 doi: 10.1002/lary.21076 – ident: e_1_2_4_109_2 doi: 10.1007/s005200000165 – ident: e_1_2_4_187_2 doi: 10.1080/1354850021000059250 – ident: e_1_2_4_58_2 doi: 10.1016/S0022-5347(17)53725-8 – ident: e_1_2_4_64_2 doi: 10.1200/JCO.2000.18.7.1570 – ident: e_1_2_4_132_2 doi: 10.3949/ccjm.75.7.531 – ident: e_1_2_4_40_2 doi: 10.1016/j.semradonc.2007.02.004 – start-page: 889 volume-title: Principles and Practice of Supportive Oncology year: 1998 ident: e_1_2_4_78_2 – volume-title: Cancer Pain Relief: With a Guide to Opioid Availability year: 1996 ident: e_1_2_4_130_2 – ident: e_1_2_4_138_2 doi: 10.1053/j.seminoncol.2003.08.025 – volume-title: Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975‐2000. NIH Pub. No. 06‐5767 year: 2006 ident: e_1_2_4_31_2 – ident: e_1_2_4_66_2 doi: 10.1016/S0022-5347(05)68000-7 – ident: e_1_2_4_49_2 doi: 10.1177/1557988309356101 – ident: e_1_2_4_96_2 doi: 10.1002/1097-0142(20010915)92:6 <1689::AID-CNCR1498>3.0.CO;2-H – ident: e_1_2_4_84_2 doi: 10.1016/j.breast.2007.07.027 – ident: e_1_2_4_15_2 doi: 10.1097/00005650-199308000-00006 – ident: e_1_2_4_41_2 doi: 10.1073/pnas.132253599 – ident: e_1_2_4_65_2 doi: 10.2165/11595820-000000000-00000 – ident: e_1_2_4_121_2 doi: 10.1002/pon.1074 – volume-title: Version 7.0.5 year: 2011 ident: e_1_2_4_9_2 – ident: e_1_2_4_183_2 doi: 10.1158/1055-9965.EPI-11-0611 – ident: e_1_2_4_8_2 – ident: e_1_2_4_184_2 doi: 10.1016/S0277-9536(99)00281-6 – ident: e_1_2_4_25_2 doi: 10.3322/caac.20001 – ident: e_1_2_4_76_2 doi: 10.1200/JCO.2004.01.120 – ident: e_1_2_4_93_2 doi: 10.1634/theoncologist.12-S1-4 – ident: e_1_2_4_6_2 doi: 10.1002/cncr.27405 – ident: e_1_2_4_176_2 doi: 10.1200/JCO.2002.10.085 – ident: e_1_2_4_90_2 doi: 10.1200/JCO.2011.39.4288 – ident: e_1_2_4_3_2 doi: 10.1002/sim.1304 – ident: e_1_2_4_92_2 doi: 10.1016/S1470-2045(11)70002-X – volume-title: National Health Interview Survey, 2000, 2005, and 2008 year: 2009 ident: e_1_2_4_175_2 – ident: e_1_2_4_21_2 doi: 10.1097/PRS.0b013e3181f958de – ident: e_1_2_4_63_2 doi: 10.6004/jnccn.2009.0076 – ident: e_1_2_4_159_2 doi: 10.1200/JCO.2010.27.9752 – ident: e_1_2_4_178_2 doi: 10.1002/pon.1703 – ident: e_1_2_4_141_2 doi: 10.1200/JCO.2011.35.9729 – volume-title: New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973‐2000. NIH Pub. No. 05‐5302 year: 2006 ident: e_1_2_4_34_2 – ident: e_1_2_4_98_2 doi: 10.1200/JCO.2003.08.163 – ident: e_1_2_4_120_2 doi: 10.1002/cncr.21488 – ident: e_1_2_4_129_2 doi: 10.1016/j.critrevonc.2008.01.008 – ident: e_1_2_4_186_2 doi: 10.1002/pon.1049 – volume-title: Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition year: 2006 ident: e_1_2_4_35_2 – ident: e_1_2_4_101_2 doi: 10.1093/jnci/djg0019 – ident: e_1_2_4_106_2 doi: 10.1016/S0959-8049(03)00545-8 – ident: e_1_2_4_74_2 doi: 10.1023/B:BREA.0000003916.39959.73 – ident: e_1_2_4_189_2 doi: 10.1037/0278-6133.23.6.595 – ident: e_1_2_4_2_2 doi: 10.1056/NEJM198507253130421 – ident: e_1_2_4_127_2 doi: 10.1093/annonc/mdm056 – ident: e_1_2_4_30_2 doi: 10.3322/canjclin.57.4.242 – ident: e_1_2_4_162_2 doi: 10.1002/cncr.20714 – ident: e_1_2_4_26_2 doi: 10.1056/NEJMsa060185 – ident: e_1_2_4_174_2 doi: 10.1200/JOP.0912001 – ident: e_1_2_4_110_2 doi: 10.1002/cncr.11253 – ident: e_1_2_4_123_2 doi: 10.1634/theoncologist.11-2-96 – ident: e_1_2_4_155_2 doi: 10.1093/jnci/djj130 – ident: e_1_2_4_168_2 doi: 10.1002/pon.1546 – ident: e_1_2_4_103_2 doi: 10.1007/s10549-007-9831-1 – ident: e_1_2_4_80_2 doi: 10.1200/JCO.2008.20.2267 – ident: e_1_2_4_157_2 doi: 10.1207/s15324796abm2903_10 – ident: e_1_2_4_42_2 doi: 10.1056/NEJMoa1102873 – ident: e_1_2_4_77_2 doi: 10.1016/S0167-8140(00)00166-3 – ident: e_1_2_4_167_2 doi: 10.3322/caac.20140 – ident: e_1_2_4_107_2 doi: 10.1200/JCO.1998.16.5.1689 – ident: e_1_2_4_27_2 doi: 10.1002/ijc.22827 – ident: e_1_2_4_89_2 doi: 10.1002/ana.410430511 – ident: e_1_2_4_134_2 doi: 10.1080/00926230490258884 – volume-title: American College of Surgeons Commission on Cancer. National Cancer Data Base, 2008 Data Submission year: 2011 ident: e_1_2_4_10_2 – ident: e_1_2_4_29_2 doi: 10.1002/cncr.22189 – ident: e_1_2_4_81_2 doi: 10.1081/CNV-100107743 – ident: e_1_2_4_160_2 doi: 10.1200/JCO.2009.26.9324 – start-page: 339 volume-title: New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973‐2000. NIH Pub. No. 05‐5302 year: 2006 ident: e_1_2_4_44_2 – ident: e_1_2_4_128_2 doi: 10.1002/cncr.25761 – ident: e_1_2_4_59_2 doi: 10.1002/cncr.22058 – ident: e_1_2_4_14_2 doi: 10.1200/JCO.2009.27.2427 – ident: e_1_2_4_88_2 doi: 10.1002/cncr.20272 – volume-title: SEER‐Medicare Data (2004‐2006) year: 2010 ident: e_1_2_4_16_2 – ident: e_1_2_4_147_2 doi: 10.1093/jnci/djr322 – ident: e_1_2_4_182_2 doi: 10.1007/s11136-011-9953-0 – ident: e_1_2_4_181_2 doi: 10.1007/s00520-006-0207-6 – ident: e_1_2_4_37_2 doi: 10.1056/NEJMoa0900386 – volume-title: NCCN Clinical Practice Guidelines in Oncology. Adult Cancer Pain. Version 2.2011 year: 2011 ident: e_1_2_4_131_2 – ident: e_1_2_4_145_2 doi: 10.3322/caac.20040 – ident: e_1_2_4_144_2 article-title: New patient‐centered care standards from the Commission on Cancer: opportunities and challenges [published online ahead of print March 20, 2012] publication-title: J Support Oncol. – ident: e_1_2_4_55_2 doi: 10.1001/jama.2011.1139 – volume: 32 start-page: 9 year: 2004 ident: e_1_2_4_62_2 article-title: National Institutes of Health State‐of‐the‐Science Panel. National Institutes of Health State‐of‐the‐Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15‐17, 2002 publication-title: J Natl Cancer Inst Monogr. – ident: e_1_2_4_99_2 doi: 10.1016/S0885-3924(03)00218-5 – ident: e_1_2_4_125_2 doi: 10.1038/sj.bjc.6602677 – ident: e_1_2_4_71_2 doi: 10.1038/nrcardio.2010.121 – ident: e_1_2_4_56_2 doi: 10.1016/j.eururo.2011.11.010 – ident: e_1_2_4_143_2 doi: 10.1001/jama.2010.258 – ident: e_1_2_4_177_2 doi: 10.1002/cncr.24588 – ident: e_1_2_4_124_2 doi: 10.1097/AOG.0b013e3181f87c4b – ident: e_1_2_4_17_2 doi: 10.1097/01.coc.0000156922.58631.d7 – ident: e_1_2_4_118_2 doi: 10.1097/00002820-198106000-00004 – ident: e_1_2_4_24_2 doi: 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9 – ident: e_1_2_4_169_2 doi: 10.1097/PPO.0b013e31818daeee – reference: - CA Cancer J Clin. 2012 Sep-Oct;62(5):348
SSID	ssj0000777
Score	2.618386
SecondaryResourceType	review_article
Snippet	Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	220
SubjectTerms	American Cancer Society Cancer Combined Modality Therapy Female Females Humans Incidence Male Neoplasms - epidemiology Neoplasms - therapy Oncology Prevalence Registries - statistics & numerical data SEER Program - statistics & numerical data Statistics Survival analysis Survival Rate - trends Survivor United States - epidemiology
SummonAdditionalLinks	– databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_mFPHF74_qlIq-KBbXJG0a8GUUhy-OPSj4VpIsfZJONre_30vSdQxFEN9aeiHhfpfkd73kDuCamVKaOE0jnRmKDgplUZZKGdkoW5YIFotEuWITfDDI3t7EsAUPi7swPj9E88PNzgy3XtsJLpWrQkLRBhFELbFDdF-YWIP1OKaZLdxA2HC5DnPuM2Z2eYQ0JvHJSW3r-2Xb1e3oG8dcpaxuz-nv_G-0u7Bdc82w541jD1qm2ofN5zqafgAkt5BPwuaweSirUTid4eoxH7vjzaG9b-RTOd-FuImTQ3jtP77kT1FdQyHSLBEiyqRhMjWsqwQyvZInQhJ0kbRhBm1oxJA_iVSXKdFU4VApEhJ8l6jPkWBadekRtKtxZU4gZEwbTWQpuShtXnvFEyUMuk80pkpREsDNQpWFrhOM2zoX7wU6GlYNhVVC4ZQQwFUj--HTavwo1VkgUtRTa4pixGYNRHQDuGw-46SwkQ5ZmfHMyzCOZCoO4Ngj2XRDbKidMRrArQPsl_6LvNfL3dPpX4TPYMsi4g_1dqD9OZmZc9jQcwRscuGM9AvkuuUI priority: 102 providerName: Wiley-Blackwell
Title	Cancer treatment and survivorship statistics, 2012
URI	https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21149 https://www.ncbi.nlm.nih.gov/pubmed/22700443 https://www.proquest.com/docview/1024540077 https://www.proquest.com/docview/1024476631
Volume	62
WOSCitedRecordID	wos000306123900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: 24P dateStart: 19970101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZ4CXHh_SiPqQguICrWJG2aExoTCA6MCfHYrUqz9IQ62Bi_HzvtCgjEhUvUqJYS2Y7zObZsgENhc23DOA5MYjk6KFwESax1QFG2JFIiVFHmmk3ITifp9VS3enAbVWmVE5voDHV_YOiNHE83o2JxTSnPXl4D6hpF0dWqhcY0zIZ0d6M-y7vHT0ssZVkzsykDBDJRWZ6Uow6fGo3bReeHamh-vZB-oMzvoNXdOpdL_93vMixWeNNvlQqyAlO2WIX5myqivgoLhDbLYs1rwNqkA0O_zj73ddH3R2M0J-8Dl-_sj2ryEx9vdbYOD5cX9-2roGqqEBgRKRUk2godW9HMFEK_XEZKM_SZjBUWlaovEFCp2OQxMzxDTnFEKDjXYcj7SpisyTdgphgUdgt8IYw1TOdaqpwK3WcyypRFf4qHPMs48-BowtnUVBXHqfHFc4qeB0khJSmkTgoeHNS0L2WdjV-pdifMTquzNko_Oe3Bfv0bTwmFPnRhB-OSRkhEV6EHm6Vg62UYxd6F4B4cO0n_sX7abrXa7mv7753swALJoMzr3YWZt-HY7sGceUcRDRswzUS34XSVxp50Y9KA2fOLTvcOZzfsFsen684H43DxRw
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NT9wwEB3xJeBSWihtWqBBwIGKqBvbieMDQqulCASsOIC0t-B4nRPKLrssFX-K39iZOAmtQNw4cEsUy478xuM38eQNwLawubZhHAcmsRwDFC6CJNY6oFO2JFIiVFFWFpuQ3W7S66mLKXis_4WhtMraJ5aOuj8w9I0cVzcjsbiWlAfD24CqRtHpal1Cw5nFqX34gyHbeP_kEPHdYezo92XnOKiqCgRGREoFibZCx1a0MoXcJ5eR0gyDBmOFxVntC2QUKjZ5zAzPOGcct2i812HI-0qYrMWx32mYRT8uKYVM9uST55fSaXS2ZIDEKXJyqNgJ-2U0Tg8GW6TZ-e8G-IzV_k-Sy13uaOm9zc9H-FDxab_tFsAnmLLFMsyfVxkDy7BIbNqJUa8A65CNj_wmu97XRd8fT9Bd3g_KfG5_3DTf85G1sM9w9SavvwozxaCwX8EXwljDdK6lyknIP5NRpizGizzkWcaZB7s1kqmpFNWpsMdNipEVoZ4S6mmJugdbTduh0xF5sdVaDW5a-ZJx-oSsB5vNY_QCdLSjCzuYuDZCInsMPfjiDKkZhlFugRDcg5-lZb0yftpptzvl1bfX3-QHLBxfnp-lZyfd0--wSHi4HOY1mLkbTew6zJl7hGu0Ua4QH67f2uT-AkVORpM
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fS-QwEB5OT8QX7_xdz9OKvigWt8m0aR6XvVsUddkHBd9Kmk2fpCur69_vTNOtLIogvrV0QkJmJvmmM_kCcIyuNC5O08hmTlKAIjHKUmMizrJlicZYJ0V92YQaDLL7ez1sanP4LIznh2h_uLFn1Os1O7h7HJXs5ZKMkLRoDfVI8QvqBfiJiYrZqAUO3xZipTxlZkdFhGMSz07Krc_f2s7vR-9A5jxmrTed_q9vDvc3rDZoM-x681iDH65ah-WbJp--AaLHSp-Ebbl5aKpR-DSl9eNlXBc4h3ziyJM5n4W0jYtNuOv_v-1dRM0tCpHFROsoMw5N6rBTaMJ6pUq0ERQkWYeOrGiEhKB0astUWFnQUCVBEno3cSxHGm3RkVuwWI0rtwMhonVWmNIoXTKzfaGSQjsKoGQsi0KKAE5mc5nbhmKcb7p4yCnU4GnIeRLyehICOGplHz2xxodSezOV5I1zPZGYYN5AUm8Ah-1ncgvOdZjKjadeBhXBqTiAba_KthvByXZEGcBprbFP-s973W6vftr9ivABLA__9fPry8HVH1hh5fgK3z1YfJ5M3V9Ysi-ku8l-bbCvZY_odw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+treatment+and+survivorship+statistics%2C+2012&rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&rft.au=Siegel%2C+Rebecca&rft.au=DeSantis%2C+Carol&rft.au=Virgo%2C+Katherine&rft.au=Stein%2C+Kevin&rft.date=2012-07-01&rft.issn=0007-9235&rft.eissn=1542-4863&rft.volume=62&rft.issue=4&rft.spage=220&rft.epage=241&rft_id=info:doi/10.3322%2Fcaac.21149&rft.externalDBID=n%2Fa&rft.externalDocID=10_3322_caac_21149
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-9235&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-9235&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-9235&client=summon